Summary of findings for the main comparison
===========================================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- --------------------------- ----------------------------- ---------------------------------- -------------------
  **Population:** children aged \< 24 months\                                                                                                                                                                                                                                                                                                  
  **Setting:** Pakistan (2 studies)\                                                                                                                                                                                                                                                                                                           
  **Intervention:** health education in the community (2 studies)\                                                                                                                                                                                                                                                                             
  **Comparison:** standard care                                                                                                                                                                                                                                                                                                                

  Outcomes                                                                                                                                                                                              Anticipated absolute effects (95% CI)\*   Relative effect(95% CI)     No of participants(studies)   Certainty of the evidence(GRADE)   

  **Standard care**                                                                                                                                                                                     **Health education**                                                                                                                   

  DTP3\                                                                                                                                                                                                 577 per 1000                              969 per 1000(629 to 1000)   RR 1.68(1.09 to 2.59)         1692(2 studies)^3^                 ⊕⊕⊕⊖Moderate^1,2^
  (Follow-up: 4-9 months)                                                                                                                                                                                                                                                                                                                      

  \***The effect in the \'health education\' group** (and its 95% CI) was based on the assumed risk in the \'standard care\' group and the **relative effect** of the intervention (and its 95% CI).\                                                                                                                                          
  **CI:** Confidence interval;**DTP3:** 3 doses of diphtheria-tetanus-pertussis containing vaccines; **RR:** risk ratio.                                                                                                                                                                                                                       

  **GRADE Working Group grades of evidence**\                                                                                                                                                                                                                                                                                                  
  **High certainty:** This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different is low.\                                                                                                                                                                              
  **Moderate certainty:** This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different is moderate.\                                                                                                                                                                          
  **Low certainty:** This research provides some indication of the likely effect. However, the likelihood that it will be substantially different is high.\                                                                                                                                                                                    
  **Very low certainty:** This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different is very high.\                                                                                                                                                             
  \'Substantially different\' implies a large enough difference that it might affect a decision.                                                                                                                                                                                                                                               
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- --------------------------- ----------------------------- ---------------------------------- -------------------

^1^ We rated down by 1 level because we judged the included studies at high risk of bias.

^2^ We rated down by 1 level because of unexplained heterogeneity of effects across studies, P value \< 0.00001, I^2^ = 68%.

^3^ Andersson [@b1]; Owais [@b10].

Background
==========

Immunisation is a powerful public health tool for improving child survival, not only by directly combating some of the key diseases and causes of child mortality, but also by providing a platform for broader health services (Andre [@b81]; Bloom [@b84]; CDC [@b87]; Clements [@b89]; JAMA [@b104]; [@b123]; Wiysonge [@b141]). The concerted global effort to use immunisation as a public health strategy began when the World Health Organization (WHO) launched the Expanded Programme on Immunization (EPI) in 1974, following the successful global smallpox eradication programme (Wiysonge [@b144]). When the EPI was launched, WHO recommended a standard immunisation schedule covering six basic antigens (i.e. tuberculosis (Bacille Calmette-Guérin (BCG)), polio, diphtheria, tetanus, pertussis, and measles), which are generally referred to as traditional EPI vaccines. With the emergence of new vaccines, more killer diseases can be prevented in infancy and adolescence. These vaccines include (but are not limited to) hepatitis B, *Haemophilus influenzae* type b (Hib), human papilloma virus, pneumococcal conjugate, rotavirus, yellow fever, meningococcal meningitis A, Japanese encephalitis, and rubella vaccines (WHO [@b135]).

The proportion of children who receive the full series of three doses of diphtheria-tetanus-pertussis containing vaccines (DTP3) by 12 months of age is traditionally used as a standard measure of the programme\'s ability to reach the target population, and is used as an indicator of the overall performance of EPI programmes ([@b122]; [@b138]). The traditional EPI vaccines are estimated to prevent 2.5 million child deaths annually (mainly from measles, pertussis, tetanus, and diphtheria), as well as to prevent severe morbidity for millions more children around the world from devastating diseases such as poliomyelitis and tuberculous meningitis (CDC [@b87]; Liu [@b115]; Machingaidze [@b116]; [@b122]; Rainey [@b125]; Wiysonge [@b140]). However, immunisation has the potential to do more; increasing coverage with existing vaccines, as well as the introduction and increased uptake of a portfolio of newly available vaccines in EPI programmes in low- and middle-income countries (LMICs), could save the lives of millions more children each year (Andre [@b81]; Brown [@b86]; Chopra [@b88]; Duclos [@b92]; Liu [@b115]; Machingaidze [@b116]; [@b138]; Wiysonge [@b142]). Despite these huge potentials, the vaccination achievements so far have been described as \'fragile\', given the outbreaks of some of these infectious diseases in LMICs (Duclos [@b92]; SAGE [@b129]; Siegfried [@b132]), and in high-income countries ([@b91]; SAGE [@b129]). These outbreaks reflect the existence of communities with partially vaccinated or unvaccinated children ([@b91]; SAGE [@b129]), which are communities whose herd immunity is not high enough to stall the transmission of these diseases.

In order to overcome these weaknesses and realise the full potential of immunisation, the \'Decade of Vaccines Collaboration\' developed the Global Vaccine Action Plan (GVAP), which was endorsed by the World Health Assembly in May 2012. The plan envisions \"a world in which all individuals and communities enjoy lives free from vaccine-preventable diseases\". The mission of the GVAP is to extend, by 2020 and beyond, the full benefit of immunisation to all people, regardless of where they are born, who they are, or where they live (WHO [@b135]).

Description of the condition
----------------------------

Global DTP3 coverage hovered around 5% in 1974, when EPI was launched, and increased very slowly to 17% in 1980 (WHO [@b136]). Through the 1980s, WHO and the United Nations Children Fund (UNICEF) led an aggressive global campaign to achieve universal childhood immunisation, by vaccinating at least 80% of all children with the six traditional EPI vaccines by 1990 (Machingaidze [@b116]; [@b122]). The global DTP3 coverage reached 76% in 1990 (WHO [@b137]). However, the progress in LMICs was slow as DTP3 coverage was only 57% in Africa and 70% in South-East Asia (UNICEF [@b133]). Up to 2006, only 27% of LMICs had DTP3 coverage above the 80% target (Rainey [@b125]). A significant improvement was reported in 2007 in LMICs, particularly in sub-Saharan Africa and South-East Asia although these two regions did not reach the 80% DTP3 coverage (Duclos [@b92]). WHO and UNICEF estimated that DTP3 coverage increased to 86% globally in 2014 (WHO [@b137]).

In spite of this improvement, about 18.7 million children under one year of age were said to be unvaccinated with DTP3 globally in 2014. Close to 70% of these children live in just 10 LMICs in Africa and South-East Asia: Democratic Republic of Congo, Ethiopia, India, Indonesia, Kenya, Mexico, Nigeria, Pakistan, South Africa, and Viet Nam (WHO [@b137]). As a consequence of this continued failure to reach optimal immunisation coverage, 1.5 million children die each year from diseases preventable by vaccines currently recommended by WHO. These include 476,000 deaths from pneumococcal disease, 453,000 from rotavirus diarrhoea, 199,000 from Hib, 195,000 from pertussis, 118,000 from measles, and 59,000 from neonatal tetanus (WHO [@b137]). Factors associated with low immunisation coverage are linked to the health system, healthcare providers, and healthcare recipients (Bloom [@b83]; Rainey [@b125]; Wiysonge [@b143]).

Some experts have observed growing concerns about vaccines, which has influenced vaccine acceptance (Bloom [@b83]; [@b91]; Feemster [@b95]; Larson [@b111]). Vaccine acceptance spans a spectrum from complete rejection to total acceptance (Feemster [@b95]). Along the spectrum is an emerging phenomenon: vaccine hesitancy (Larson [@b111]). The Strategic Advisory Group of Experts on Immunisation (SAGE) defines vaccine hesitancy as a behaviour that includes confidence, complacency, and convenience. According to SAGE, vaccine-hesitant people may accept all vaccines but with concerns, may accept only some vaccines or delay in taking up vaccines, or may totally reject all vaccines (Larson [@b111]).

There are varied reasons for failing to achieve universal coverage in different settings. Such reasons span from inaccessible services and poor logistic support, to political instability, including wars and public perceptions (Bloom [@b83]). Evidence is required to inform strategies to reach partially vaccinated and unvaccinated people in these countries. Such strategies also need to be tailored to local issues, needs, and conditions.

Description of the intervention
-------------------------------

Several experts have highlighted the wide range of issues affecting uptake of vaccines in various settings (Bloom [@b83]; [@b91]; Mills [@b119] Munoz [@b120]). The issues vary between and within settings due to social, economic, cultural, geographical, political, and religious factors. Therefore, potential interventions are also likely to vary across different settings. Based on the findings from reviews on this, [Table 1](#tabl34){ref-type="table"} presents a matrix of interventions to address the issues. Broadly, these strategies could include recipient-oriented interventions, for example, recipient recalls and reminders, health education of clients, teaching recipients skills; provider-oriented interventions, such as audit and feedback and chart-based or computerised provider reminders; and health system interventions, such as outreach programmes and improved quality of delivery of care (Lewin [@b114]). These could be delivered as single or multi-faceted interventions.

How the intervention might work
-------------------------------

The various interventions serve different purposes. [Table 1](#tabl34){ref-type="table"} presents this matrix. Some interventions can be used for both recipients and providers, for example, remind/recall interventions could target both caregivers and healthcare providers.

Why it is important to do this review
-------------------------------------

In many LMICs, immunisation coverage is low (WHO [@b136]; UNICEF [@b134]), routine immunisation systems are weak (Machingaidze [@b116]), and community knowledge of immunisation is low (Zipursky [@b146]). The target of GVAP was to achieve DTP3 coverage of at least 90% in all countries by 2015. While 129 countries achieved the 90% coverage target by 2014, the 10 countries with the largest numbers of unimmunised children are all low-income or lower- to middle-income countries (SAGE [@b129]; WHO [@b137]).

Making well-informed decisions about how best to achieve and sustain high and equitable immunisation coverage in these countries will depend partly on decision makers accessing the best scientific evidence about what interventions work, and integrating this evidence into their national health systems (Lewin [@b112]). One previous Cochrane review assessed recipient-oriented reminders and recalls (Jacobson [@b103]). The evidence indicated that reminding people to receive vaccinations through postcards, letters, or telephone calls increased immunisation uptake. This strategy generally relies on setting up an efficient computerised vaccination registry or other practice-based information systems to track clients\' vaccination status and eligibility for recommended vaccines, and also an efficient communication system to send reminders to clients. These technologies are lacking in many LMICs. This review examines the effects of strategies that utilise available resources in LMICs for improving vaccination coverage in the bid to provide evidence on appropriate strategies to improve and sustain immunisation coverage in these settings. In addition, it also explores provider-oriented interventions (Djibuti [@b7]), and health system interventions (Brugha [@b5]), towards improving immunisation coverage.

This is the first update of the Cochrane review published in 2011 ([@b147]), and complements two other Cochrane reviews conducted under the auspices of the \'Communicate to Vaccinate\' project (Lewin [@b114]), which have a worldwide focus and assess the effects of face-to-face (Kaufman [@b107]) and community-directed interventions (Saeterdal [@b128]) to inform or educate about childhood vaccination. It also complements Jacobson Vann\'s review on participant reminder and recall systems to improve immunisation rates (Jacobson [@b103]) by providing evidence on the wide range of interventions covering recipients, providers, and the health system that can be used to improve vaccination coverage.

Objectives
==========

To evaluate the effectiveness of intervention strategies to boost and sustain high childhood immunisation coverage in LMICs.

Methods
=======

Criteria for considering studies for this review
------------------------------------------------

### Types of studies

We included:

randomised controlled trials (RCTs), with randomisation at either individual or cluster level. For cluster RCTs, we only included those with at least two intervention and two control clusters.non-randomised controlled trials (nRCTs), with allocation at either individual or cluster level. We included studies that allocated by alternation between groups, by the use of birth dates or weekdays, or by other non-random methods. For cluster trials, we only included those with at least two intervention and two control clusters.interrupted time series studies (ITS) and repeated measures studies, with a clearly defined time point when the intervention occurred and at least three data points before and three after the intervention.controlled before-after (CBA) studies with a minimum of two intervention and two control sites; comparable timing of the periods of study for the control and intervention groups; and comparability of the intervention and control groups on key characteristics.

We excluded:

CBA studies, cluster RCTs, and nRCTs that had only two study locations, in accordance with Effective Practice and Organisation of Care (EPOC) criteria for inclusion of studies (EPOC [@b93]).

### Types of participants

Studies conducted in LMICs (World [@b145]) that included:

children under five years of age receiving WHO-recommended vaccines through routine childhood immunisation services;caregivers of children who were receiving vaccines through routine childhood immunisation services;healthcare workers administering vaccines through routine childhood immunisation services;or a combination of these.

For the purposes of this review, we defined routine childhood immunisation services as regularly scheduled immunisation services to children under five years of age, whether these services were offered at healthcare facilities, at fixed outreach sites, or by mobile health teams in communities (Machingaidze [@b117]).

We limited the review to LMICs because of the continued failure to meet immunisation target and the weak routine immunisation system in this setting.

### Types of interventions

#### Interventions

Recipient-oriented interventions, for example:interventions to improve communication about childhood immunisation, including to (Willis [@b139]):inform or educate;remind or recall;teach skills;provide support;facilitate decision making;enable communication;enhance community ownership;meet vaccination requirement for school entry;use recipient incentives.Provider-oriented interventions, for example:any intervention to reduce missed opportunities for childhood vaccination (e.g. audit and feedback, provider reminders, supportive supervision);health education, training, and refresher courses for providers.Health system interventions, for example:interventions to improve the quality of services, such as provision of a reliable cold chain system, provision of transport for vaccination, vaccine stock management;outreach programmes (e.g. school immunisation outreach programmes, door-to-door canvassing (channeling);expanded services (e.g. extended hours for immunisation);increases in budgets for immunisation;integration of immunisation services with other services;plans of action for immunisation coverage and disease reduction goals.Multi-faceted (i.e. any combination of the above categories of) interventions.Other interventions intended to improve immunisation coverage.

#### Comparisons

Standard immunisation practices in the study setting.Different interventions, or similar interventions implemented with different degrees of intensity.

### Types of outcome measures

#### Primary outcomes

Proportion of children who received DTP3 by one year of age.Proportion of children who received all recommended vaccines by two years of age.

#### Secondary outcomes

Proportion of children who received the vaccine under study.Number of children under five years of age fully immunised with all scheduled vaccines.Occurrence of vaccine preventable diseases.Costs of the intervention.Attitudes of caregivers and clients towards immunisation.Adverse events following immunisation (AEFI).

Search methods for identification of studies
--------------------------------------------

### Electronic searches

We placed no language or date restrictions on the search strategy. We translated the MEDLINE (Ovid) search strategy into the other databases using the appropriate controlled vocabulary.

We searched the following electronic databases on the dates indicated:

Cochrane Central Register of Controlled Trials (CENTRAL), 2016, Issue 4, including the Cochrane EPOC Group Specialized Register (searched 12 May 2016)MEDLINE In-Process and Other Non-Indexed Citations, MEDLINE Daily and MEDLINE 1946 to Present, OvidSP (searched 12 May 2016)CINAHL 1981 to present, EbscoHost (searched 12 May 2016)Embase 1980 to 2014 Week 34, OvidSP (searched 2 September 2014)LILACS (VHL) (searched 2 September 2014)Sociological Abstracts 1952 - current, ProQuest (searched 2 September 2014)

On 12 May 2016 we searched only CENTRAL, MEDLINE, and CINAHL. Embase, Socioligical Abstracts, and LILACs were not searched for the following reasons. All 14 studies included in the review after the 2014 searches are indexed in CENTRAL, and 11 of the 14 studies are indexed in MEDLINE. The three studies not indexed in MEDLINE are not indexed in EMBASE. None of the 14 studies are indexed in Sociological Abstarcts. The three studies not indexed in MEDLINE are not indexed in LILACS. All of the search strategies are in [Appendix 1](#app01){ref-type="app"}.

### Searching other resources

We also searched the Cochrane Database of Systematic Reviews (CDSR) and the Database of Abstracts of Reviews of Effectiveness (DARE) for related reviews. We searched the reference lists of relevant reviews for potentially eligible studies (Batt [@b82]; Bordley [@b85]; Glenton [@b98]; Harvey [@b101]; Jacobson [@b103]; Johri [@b105]; Kaufman [@b107]; Kendrick [@b108]; Lagarde [@b109]; Lagarde [@b110]; Pegurri [@b124]; Ryman [@b127]; Saeterdal [@b128]). We also searched the reference lists of included studies for potentially eligible studies. We did a citation search for all included studies in Science Citation Index and Social Sciences Citation Index, 1975 to present; Emerging Sources Citation Index 2015 to present, ISI Web of Science (searched 2 July 2016)

We searched the following Trials Registries

· International Clinical Trials Registry Platform (ICTRP), Word Health Organization (WHO) <http://www.who.int/ictrp/en/> (searched 5 July 2016)

· ClinicalTrials.gov, US National Institutes of Health (NIH) <http://clinicaltrials.gov/> (searched 5 July 2016)

Data collection and analysis
----------------------------

### Selection of studies

At least two review authors independently screened the titles and abstracts of papers identified in the search output for potentially eligible studies. We retrieved full texts of potentially eligible studies for further assessment, and two review authors independently applied the inclusion criteria to these publications. We resolved disagreements about the inclusion of studies through discussion and consensus between the two review authors; and involved a third review author if the disagreement was not resolved. We obtained methodological advice from the EPOC editorial base for unresolved issues. The [Characteristics of excluded studies](#sec02){ref-type="sec"} presents reasons for excluding studies.

### Data extraction and management

All review authors developed and reviewed a data extraction form. Two review authors independently carried out data extraction and risk of bias assessment. We resolved disagreements in data extraction by consensus between the two review authors, with arbitration by a third author as required. The data extracted into an Excel spreadsheet included the following:

Setting of the study.Type of study: distinguishing between individual RCTs, cluster RCTs, nRCTs, CBA studies, and ITS studies.Type of participants: children, caregivers, and providers.Type of interventions: categorised into participant and community, provider, health system, and multi-faceted.Types of outcomes measured: data on outcome measures such as proportion of children immunised with different antigens based on the different interventions.

### Assessment of risk of bias in included studies

Two review authors applied the EPOC risk of bias criteria for RCTs, nRCTs, CBAs, and ITS studies to determine the risk of bias in included studies (EPOC [@b94]). We resolved disagreements by discussion and consensus, with arbitration by a third review author as required. 

Each criterion was scored as \'low risk\', \'unclear risk\', or \'high risk\' ([Characteristics of included studies](#sec03){ref-type="sec"} table). [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} present the risk of bias for each included study. We considered a study as having a \'low risk of bias\' if all criteria prescribed by EPOC were scored as \'Yes\'; \'unclear risk of bias\' if one or more criteria were scored as \'Unclear\'; and \'high risk of bias\' if one or more key criteria scored as \'No\'. The key criteria included allocation concealment, completeness of outcome data, blinding of outcome assessors, and protection against contamination for RCTs and NRCTs; and independence of intervention from other changes, possibility of intervention affecting data collection, completeness of outcome data, and blinding of outcome assessors for ITS studies.

![Methodological quality summary: review authors\' judgements about each methodological quality item for each included study.](CD008145-0001-f1){#fig1}

![Methodological quality graph: review authors\' judgements about each methodological quality item presented as percentages across all included studies.](CD008145-0001-f2){#fig2}

### Measures of treatment effect

We used the risk ratio (RR) for dichotomous data. We planned to calculate the mean difference (MD) for costs and any other analysis of continuous data but none of the included studies reported these types of data. We reported 95% confidence intervals (CI) for all measures.

### Unit of analysis issues

We included cluster RCTs in the meta-analysis after making adjustments for design effect using standard procedures (Rao [@b126]), and the formula: design effect = 1 + (m - 1)r, where m was the mean cluster size and r was the intra-cluster correlation coefficient (ICC). Using data from Andersson [@b1], we calculated the ICC for measles to be 0.25 and for DTP3 to be 0.14. We used this to estimate the adjusted standard error for the data of Andersson [@b1]; Banerjee [@b2]; Barham [@b3]; Brugha [@b5]; Dicko [@b6]; Maluccio [@b8]; and Robertson [@b12] none of the data from the cluster RCTs were appropriately adjusted for clustering. We entered data from Dicko [@b6] as absolute figures into Review Manager 5 (RevMan 2014) and calculated RRs; consequently, we applied the ICC to adjust for cluster effect.

### Dealing with missing data

We contacted the authors of two studies to obtain missing data (Djibuti [@b7]; Morris [@b9]). Morris [@b9] responded, and we used the additional data to estimate the ICC for the study. Additional data received included the absolute number of events in each arm of the study for the Morris [@b9] study; we estimated the ICC for mumps, measles, rubella (MMR) (0.013) and DTP1 (0.0377) for the post-intervention assessment only. We then used the ICC to adjust the standard error for the two outcomes from this study that we included in this review.

Five studies followed up the same set of participants post-intervention (Bolam [@b4]; Brugha [@b5]; Owais [@b10]; Usman [@b13]; Usman [@b14]). There were no missing data in three of these studies (Brugha [@b5]; Usman [@b13]; Usman [@b14]), and missing data were minimal (2%) in one study (Owais [@b10]) and high (greater than 20%) in Bolam [@b4] study. Robertson [@b12] accounted for missing data and applied intention-to-treat analysis. The remaining studies had independent sampling at pre- and post-intervention stages so missing data from loss to follow-up was not applicable in these studies (Andersson [@b1]; Banerjee [@b2]; Barham [@b3]; Dicko [@b6]; Djibuti [@b7]; Maluccio [@b8]; Morris [@b9]; Pandey [@b11]).

### Assessment of heterogeneity

We reviewed heterogeneity in the setting, interventions, and outcomes of included studies in order to make a qualitative assessment of the extent to which the included studies were similar to each other. We examined the forest plots visually to assess the levels of heterogeneity. We considered meta-analyses with a P value for the Chi^2^ test of less than 0.1 to have considerable statistical heterogeneity. We used an I^2^ statistic of 50% or more to quantity the level of statistical heterogeneity. We planned to subject such meta-analyses to subgroup analyses for investigation of heterogeneity (see [Subgroup analysis and investigation of heterogeneity](#sec05){ref-type="sec"}). However, due to the paucity of data, such subgroup analysis was not feasible.

### Assessment of reporting biases

Test for asymmetry with a funnel plot was not feasible because the number of included studies for meta-analysis was too few.

### Data synthesis

We planned to pool data from studies with similar interventions (participant or community, provider, health system, multi-faceted), grouped by study design (RCTs, nRCTs, CBAs, ITS studies), in a meta-analysis using the random-effects model. For studies that reported only effect estimates with the measures of uncertainty, but without numbers of participants and numbers of events, we planned to analyse the effect estimate using the generic inverse variance approach. ITS studies were to be reported as changes in level and slope. We selected the random-effects model as the default procedure in the analysis due to heterogeneity, based on the assumption of random distribution of the variation in the effects of interventions in the different studies.

### Subgroup analysis and investigation of heterogeneity {#sec05}

We planned to explore anticipated differences in the impact of interventions across settings and mode of delivery of the interventions. We planned the following subgroup analyses:

Setting of the study (rural, urban).Individual or group intervention.Single or multi-faceted/integrated intervention.Conditional or non-conditional incentive.Facility- or community-based intervention.

Due to paucity of data subgroup analysis was only possible for facility- versus community-based health education.

### Sensitivity analysis

We planned to perform a sensitivity analysis based on risk of bias and missing data if we found sufficient data: however, available data were insufficient to perform this analysis. Due to diversity in the reported outcomes across studies, we pooled data for only three interventions, namely health education for DTP3, health education plus redesigned cards for DTP3, and monetary incentive for full immunisation. There was heterogeneity in the pooled data on health education and health education plus redesigned card interventions. This could be attributed to the high risk of bias of included studies and the difference in the mode of delivery of the interventions.

#### Assessment of certainty of evidence

We assessed certainty of the evidence using GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) (Guyatt [@b100]; Higgins [@b102]). We entered data for key interventions into the Grade Profiler and graded the certainty of evidence for the outcomes as \'high\', \'moderate\', \'low\', and \'very low\', defined as follows:

**High certainty:** this research provided a very good indication of the likely effect. The likelihood that the effect will be substantially different was low.

**Moderate certainty:** this research provided a good indication of the likely effect. The likelihood that the effect will be substantially different was moderate.

**Low certainty:** this research provided some indication of the likely effect. However, the likelihood that it will be substantially different was high.

**Very low certainty:** this research did not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different was very high.

\'Substantially different\' implies a large enough difference that it might affect a decision.

Results
=======

Description of studies
----------------------

### Results of the search

The electronic and supplementary searches yielded 10158 records, after removing duplicates. Following screening of titles and abstracts, we selected 79 studies for full text screening; 14 were eligible for inclusion in the review; we excluded 54, and 11 studies are awaiting assessment ([3](#fig3){ref-type="fig"}). In this update, we added an additional eight studies (Banerjee [@b2]; Barham [@b3]; Bolam [@b4]; Dicko [@b6]; Maluccio [@b8]; Owais [@b10]; Robertson [@b12]; Usman [@b14]) to the six studies included in the first version of the review ([@b147]).

![Study flow diagram.](CD008145-0001-f3){#fig3}

### Included studies

#### Study design and setting

Fourteen studies met the inclusion criteria (Andersson [@b1]; Banerjee [@b2]; Barham [@b3]; Bolam [@b4]; Brugha [@b5]; Dicko [@b6]; Djibuti [@b7]; Maluccio [@b8]; Morris [@b9]; Owais [@b10]; Pandey [@b11]; Robertson [@b12]; Usman [@b13]; Usman [@b14]). Ten studies were cluster RCTs (Andersson [@b1]; Banerjee [@b2]; Barham [@b3]; Brugha [@b5]; Dicko [@b6]; Djibuti [@b7]; Maluccio [@b8]; Morris [@b9]; Pandey [@b11]; Robertson [@b12]). Of these, Brugha [@b5] and Robertson [@b12] were matched cluster RCTs and Djibuti [@b7] used stratified cluster sampling. The remaining four studies were individually randomised controlled trials (Bolam [@b4]; Owais [@b10]; Usman [@b13]; Usman [@b14]). The unit of analysis was the participant in all the studies except Morris [@b9] and Pandey [@b11], in which household was the unit of analysis. There were no nRCTs, CBAs, or ITS studies among the included studies.

##### Location of studies

The studies were conducted in Georgia (Djibuti [@b7]), Ghana (Brugha [@b5]), Honduras (Morris [@b9]), India (Banerjee [@b2]; Pandey [@b11]), Mali (Dicko [@b6]), Nepal (Bolam [@b4]), Pakistan (Andersson [@b1]; Owais [@b10]; Usman [@b13]; Usman [@b14]), Mexico (Barham [@b3]), Nicaragua (Maluccio [@b8]), and Zimbabwe (Robertson [@b12]).

##### Participants

Owais [@b10] recruited children aged less than six weeks; Usman [@b13] and Usman [@b14] included children registering for DTP1 (which the authors noted was given at six weeks of age in the country); Banerjee [@b2] included children aged from birth to six months; Dicko [@b6] recruited children aged from birth to 23 months; Andersson [@b1] included children aged 12 to 23 months; and Brugha [@b5] studied children who were aged 12 to 18 months. Barham [@b3] studied children aged 12 to 18 months and Maluccio [@b8] studied children aged from birth to 30 months. Robertson [@b12] studied children under the age of five years. Participants in four studies were adults: primary healthcare workers (Djibuti [@b7]), the general population (Pandey [@b11]), pregnant women (Morris [@b9]), and postpartum women (Bolam [@b4]). The adults were targeted with a view to improving childhood immunisation coverage.

##### Outcomes

Outcome measurements were similar at baseline between intervention and control groups except for Dicko [@b6]; the researchers did not adjust for this baseline difference.

##### Sampling

Five studies carried out independent sampling in the pre- and post-intervention periods (Andersson [@b1]; Banerjee [@b2]; Dicko [@b6]; Djibuti [@b7]; Maluccio [@b8]). Morris [@b9] and Barham [@b3] had independent sampling for each outcome and for each arm of the intervention groups. Seven studies followed up the same participants at pre- and post-intervention (Bolam [@b4]; Brugha [@b5]; Owais [@b10]; Pandey [@b11]; Robertson [@b12]; Usman [@b13]; Usman [@b14]).

#### Interventions

The individual studies evaluated interventions as follows:

Recipient-oriented interventions.Health education on the importance of completion of the immunisation schedule, and on other immunisation-related issues.Health education plus \'reminder-type\' immunisation cards to remind caregivers of their next immunisation appointment.Easy to understand pictorial card using simple language to explain how vaccines save children\'s lives, and where the vaccination centre was located.Monetary incentives to increase demand for preventive healthcare interventions.Conditional and unconditional cash transfers to encourage clinic attendance for child development services.Provider-oriented interventions.Training of immunisation district managers, together with supportive supervision and audit and feedback regarding solving problems on immunisation services.Training of health providers on valid doses for vaccination.Health system-oriented interventions.Home visits to identify unimmunised children.Regular immunisation outreach sessions in the villages to ensure regular availability of immunisation services.Integration of immunisation with intermittent preventive treatment of malaria to support child health interventions.Multi-faceted interventions.Health system plus provider-oriented interventions.Health system plus provider-oriented plus recipient-oriented interventions.Reach every district approach: a combination of planning, outreach, community mobilisation, supportive supervision, and monitoring.

See below for more detail of these interventions.

##### Recipient-oriented interventions

###### Health education

Health education interventions included evidence-based discussions in the community on the prevalence of measles among children and the importance of childhood immunisation in Pakistan (Andersson [@b1]); an information campaign in India that involved presentation of audiotape messages, and distribution of posters and leaflets in the community (Pandey [@b11]); and three targeted pictorial messages regarding vaccines administered by trained lay/community health workers at the mothers\' homes in Pakistan (Owais [@b10]). The first key pictorial message highlighted how vaccines save children\'s lives. The second message provided logistic information about the address and location of the local vaccination centres. The third key message emphasised the significance of retaining immunisation cards, and the role they could play at the time of the child\'s school admissions. A copy of these pictorial messages was left with the mother. Three studies in Nepal and Pakistan provided health education in the health facility on the importance of completion of the immunisation schedule (Bolam [@b4]; Usman [@b13]; Usman [@b14]). In the Bolam [@b4] study in Nepal, one arm had only one-to-one facility-based education after delivery and before discharge from the hospital, the second arm had only a one-to-one education session in the mothers\' homes three months after delivery, while the third arm included both one-to-one health education immediately after birth and three months later. The last arm was included in the study.

###### Monetary incentives

Barham [@b3] in Mexico combined conditional cash transfers with free provision of health and education services. The conditions for the cash transfer included receiving regular immunisation, growth monitoring, mother\'s attendance at health, hygiene, and nutrition education programs; and nutritional supplements for children aged from birth to two years and for pregnant and lactating mothers.

In Nicaragua, one of the interventions in Maluccio [@b8] was a monthly \"food security\" cash transfer (\"bono alimentario\" = USD224 per year = 13% of total amount of household expenditures in beneficiary households before the programme), conditional on attendance at monthly health educational workshops, on bringing their children aged under five for free scheduled preventive childcare appointments (which include the provision of anti-parasites drugs, and vitamins and iron supplements), on having up-to-date vaccination, and on adequate weight gain. Morris [@b9] assessed the effect of withdrawing monetary vouchers if the mothers were not up-to-date with routine antenatal care and well-child preventive health care, and if the child did not attend school regularly.

Robertson [@b12] in Zimbabwe compared two interventions. Both included a cash transfer of USD18 per household and USD4 per child every two months. In one of the arms, the transfer was on the condition that: those aged below 18 years with no birth certificate applied for one within three months; children aged under five years were up-to-date with immunisation, and attended growth monitoring clinics; children aged from six to 17 years had 90% monthly attendance at school; and a representative of every household attended two-thirds of local parenting skills classes. In the second arm there were no conditions attached to the cash transfer.

###### Health Education plus \'reminder-type\' immunisation card

Two studies evaluated an enlarged immunisation card, designed to remind mothers of immunisation appointments (Usman [@b13]; Usman [@b14]).

##### Provider-oriented interventions

Interventions targeting providers in Georgia included training in continuous supportive supervision, development of supportive supervision guidelines, and tools for immunisation district managers (Djibuti [@b7]).

##### Health system interventions

###### Home visits

Brugha [@b5] reported on the effects of home visits on childhood immunisation in Ghana: undergraduate students conducted the home visits, which aimed to identify non-immunised children and refer them for immunisation at the health centre. Another review considered these students to be lay/community health workers (Glenton [@b98]).

###### Integration of services

The Dicko [@b6] study assessed the effects of integrating immunisation service delivery with intermittent preventive treatment of malaria in infants.

###### Regular immunisation outreach sessions

One study assessed the effects of regular monthly immunisation camps (Banerjee [@b2]). This intervention focused on ensuring the regular availability of immunisation services. It consisted of a mobile immunisation team, including a nurse and assistant, who conducted monthly immunisation camps in villages. The camp was held on a fixed date and time every month in each village.

##### Multi-faceted (health system plus provider interventions)

One arm of the Morris [@b9] study set up quality assurance (QA) teams in rural Honduras in health centres allocated to the intervention. The team, with wide representation from the local communities, was trained on QA methods. They produced work plans that could include minor structural repairs to health centres and the purchase of equipment, materials, and essential drugs. This arm of the study also included training of lay nutrition promoters who conducted monthly weighing of children aged less than two years and counselling of mothers. This intervention was not carried out as stipulated in the protocol, as only 17% of the total budget for the intervention was disbursed.

QA training was limited to only the introduction to the QA course. It was not clear what the composition of the QA course was. However, QA usually aims at ensuring that standards are met. This assures the service users of the quality of services and may encourage increased utilisation of services.

One arm of the study by Banerjee and colleagues assessed a regular once-monthly immunisation camp complemented with small material incentives in India (Banerjee [@b2]). The investigators offered parents 1 kg of raw lentils per immunisation administered and a set of \"thalis\" (metal plates used for meals) on completion of a child\'s full immunisation. The value of the lentils was about USD1, equivalent to three-quarters of one day\'s wage, and the value of the \"thalis\" was about USD2.00

#### Comparison

The comparison groups received routine care in five studies (Andersson [@b1]; Brugha [@b5]; Dicko [@b6]; Morris [@b9]; Usman [@b13]). The study authors did not state what comprised routine care. The comparison group received no interventions in seven studies (Banerjee [@b2]; Barham [@b3]; Bolam [@b4]; Djibuti [@b7]; Maluccio [@b8]; Pandey [@b11]; Usman [@b14]). In the Owais [@b10] study, the comparison group received verbal general messages (while the intervention group received three targeted pictorial messages). In the Robertson [@b12] study, the comparison group received unconditional cash transfers.

#### Outcomes

Eleven studies provided data on the proportion of the target population that was fully immunised (by age) by the recommended vaccine (Andersson [@b1]; Banerjee [@b2]; Bolam [@b4]; Brugha [@b5]; Dicko [@b6]; Djibuti [@b7]; Maluccio [@b8]; Owais [@b10]; Robertson [@b12]; Usman [@b13]; Usman [@b14]). Other outcomes reported were: DTP3 coverage (Andersson [@b1]; Bolam [@b4]; Dicko [@b6]; Owais [@b10]; Usman [@b13]; Usman [@b14]); percentage change in immunisation coverage over time (Andersson [@b1]; Morris [@b9]); tetanus toxoid coverage in children (Pandey [@b11]); received at least one vaccine (Pandey [@b11]); oral polio coverage (Brugha [@b5]); completion of schedule (Brugha [@b5]); cost of the intervention (Andersson [@b1]); and coverage for tuberculosis and measles vaccines (Barham [@b3]).

Nine studies measured outcomes at the participant level (Andersson [@b1]; Banerjee [@b2]; Bolam [@b4]; Brugha [@b5]; Dicko [@b6]; Djibuti [@b7]; Owais [@b10]; Usman [@b13]; Usman [@b14]); while five studies measured the outcome at the household level (Barham [@b3]; Maluccio [@b8]; Morris [@b9]; Pandey [@b11]; Robertson [@b12])..

#### Follow-up

The period of follow-up varied between studies from three months to four years. Two studies had no loss to follow-up (Usman [@b13]; Usman [@b14]), three studies had 2% to 5% loss to follow-up (Morris [@b9]; Owais [@b10]; Pandey [@b11]), and two studies had loss to follow-up of 17% or more (Banerjee [@b2]; Bolam [@b4]). Five studies had two independent samples for pre- and post- follow-up (Andersson [@b1]; Barham [@b3]; Dicko [@b6]; Djibuti [@b7]; Maluccio [@b8]), while Brugha [@b5] did not account for loss to follow-up. Robertson [@b12] had less than 4% loss to follow-up.

### Excluded studies

We excluded 54 potentially studies for reasons provided in the [Characteristics of excluded studies](#sec02){ref-type="sec"} table.

Eleven studies are awaiting assessment of their eligibility (see [Characteristics of studies awaiting classification](#sec04){ref-type="sec"} table)

Risk of bias in included studies
--------------------------------

Based on our pre-defined criteria, we assessed no study as having a low risk of bias; one study had unclear risk of bias (Owais [@b10]), and the remaining 13 studies had high risk of bias.

### Allocation

The risk of selection bias (allocation concealment) was low for three studies (Andersson [@b1]; Banerjee [@b2]; Dicko [@b6]), unclear for seven studies (Bolam [@b4]; Brugha [@b5]; Djibuti [@b7]; Owais [@b10]; Pandey [@b11]; Usman [@b13]; Usman [@b14]), and high for four studies (Barham [@b3]; Maluccio [@b8]; Morris [@b9]; Robertson [@b12]).

### Blinding

Risk of bias in relation to blinding of participants, personnel, and outcome assessments was low for six studies (Andersson [@b1]; Banerjee [@b2]; Bolam [@b4]; Owais [@b10]; Pandey [@b11]; Robertson [@b12]), unclear for three studies (Dicko [@b6]; Djibuti [@b7]; Morris [@b9]), and high for five studies (Barham [@b3]; Brugha [@b5]; Maluccio [@b8]; Usman [@b13]; Usman [@b14]).

### Incomplete outcome data

The risk of attrition bias (completeness of outcome data) was low for nine studies (Andersson [@b1]; Dicko [@b6]; Djibuti [@b7]; Morris [@b9]; Owais [@b10]; Pandey [@b11]; Robertson [@b12]; Usman [@b13]; Usman [@b14]), unclear for two studies (Barham [@b3]; Brugha [@b5]), and high for three studies (Banerjee [@b2]; Bolam [@b4]; Maluccio [@b8]).

### Other potential sources of bias

The risk of contamination was low for four studies (Banerjee [@b2]; Bolam [@b4]; Owais [@b10]; Usman [@b14]), unclear for five studies (Andersson [@b1]; Brugha [@b5]; Djibuti [@b7]; Pandey [@b11]; Usman [@b13]), and high for five studies (Barham [@b3]; Dicko [@b6]; Maluccio [@b8]; Morris [@b9]; Robertson [@b12]).

Effects of interventions
------------------------

See: [**Summary of findings for the main comparison** Community-based health education for improving childhood immunisation coverage](#tbls1){ref-type="table"}; [**Summary of findings 2** Facility-based health education plus redesigned reminder card for improving childhood immunisation coverage](#tbls2){ref-type="table"}; [**Summary of findings 3** Monetary incentives for improving childhood immunisation coverage](#tbls3){ref-type="table"}; [**Summary of findings 4** Home visits for improving childhood immunisation coverage](#tbls4){ref-type="table"}; [**Summary of findings 5** Immunisation outreach with and without incentives for improving childhood immunisation coverage](#tbls5){ref-type="table"}; [**Summary of findings 6** Integration of immunisation with other health services for improving childhood immunisation coverage in low- and middle-income countries](#tbls6){ref-type="table"}

### Primary outcomes

#### Proportion of children who received DTP3 by one year of age

##### Recipient-oriented interventions versus standard care

These interventions included health education, use of a combination of redesigned cards and health education, and a monetary incentive.

###### Health education

Included studies considered both community- and facility-based health education.

Andersson [@b1] compared community-based health education with standard care; Owais [@b10] compared community-based health education with general health promotion given verbally; and Pandey [@b11] compared community-based health education with no intervention.

Community-based health education probably improved coverage of DTP3 (RR 1.68, 95% CI 1.09 to 2.59; I^2^ = 68%; [Analysis 1.2](#fig102){ref-type="fig"}). Overall, there was high heterogeneity between the studies, probably due to the differing study methods. Certainty of evidence for community-based health education interventions was moderate ([Table 1](#tbls1){ref-type="table"}). Pandey [@b11] did not report DTP3 coverage and was, therefore, not included in this pooled analysis.

Three studies assessed facility-based health education, and found substantial heterogeneity of effects (heterogeneity P value \< 0.0001; I^2^ = 91%: [Analysis 1.2](#fig102){ref-type="fig"}) (Bolam [@b4]; Usman [@b13]; Usman [@b14]). As we were unable to explain the heterogeneity, we did not report the pooled result. The findings from the three studies showed that the impacts of facility-based education on improving DTP3 uptake range from little to no effect (Bolam [@b4]: RR 1.01, 95% CI 0.95 to 1.08) to potentially important benefits (Usman [@b13]: RR 1.18, 95% CI 1.05 to 1.33; and Usman [@b14]: RR 1.50, 95% CI 1.27 to 1.77).

###### Health education plus \'reminder-type\' immunisation card

We found low-certainty evidence that combining facility-based health education with a redesigned \'reminder-type\' immunisation card may improve DTP3 coverage (RR 1.50, 95% CI 1.21 to 1.87; I^2^ = 77%; [Analysis 2.1](#fig201){ref-type="fig"}; [Table 2](#tbls2){ref-type="table"}) (Usman [@b13]; Usman [@b14]).

##### Provider-oriented interventions versus usual care

One study assessed the impact on immunisation coverage of training immunisation managers to provide supportive supervision for health providers (Djibuti [@b7]). This study provided low-certainty evidence that the intervention had little or no effect on coverage for DTP3. The difference in coverage between the intervention and control groups was 4.3% (P value = 0.285).

##### Integration of immunisation with other healthcare services versus standard care

The Dicko [@b6] study provided low-certainty evidence that integrating immunisation services with intermittent prophylactic treatment of malaria in infants may improve DTP3 coverage (RR 1.92, 95% CI 1.42 to 2.59; [Analysis 6.2](#fig602){ref-type="fig"}; [Table 6](#tbls6){ref-type="table"}).

#### Proportion of children who received all recommended vaccines by two years of age

##### Monetary incentives or disincentives versus no intervention

One study in Nicaragua provided low-certainty evidence that monetary incentives may have little or no effect on coverage of all vaccines among children aged 12 to 23 months (RR 1.03, 95% CI 0.83 to 1.28; [Analysis 3.2](#fig302){ref-type="fig"}) (Maluccio [@b8]). One additional study from Zimbabwe provided low-certainty evidence on the effects of monetary incentives (Robertson [@b12]).

Pooled data from these two studies indicated that, overall, there was low-certainty evidence that monetary incentives may have little or no effect in improving vaccination coverage, although the CI included an important benefit (RR 1.05, 95% CI 0.90 to 1.23; [Analysis 3.2](#fig302){ref-type="fig"}; [Table 3](#tbls3){ref-type="table"}) (Maluccio [@b8]; Robertson [@b12]).

##### Immunisation outreach sessions versus no intervention

The Banerjee [@b2] study provided low-certainty evidence that regular once-monthly reliable immunisation outreach may increase the coverage for full immunisation (RR 3.09, 95% CI 1.69 to 5.67; [Analysis 5.1](#fig501){ref-type="fig"}; [Table 5](#tbls5){ref-type="table"}).

##### Multi-faceted interventions

###### Integration of immunisation to other healthcare services versus standard care

There was low-certainty evidence that integrating immunisation services with intermittent prophylactic treatment of malaria in infants may improve DTP3 coverage (RR 1.92, 95% CI 1.42 to 2.59; [Analysis 6.2](#fig602){ref-type="fig"}; [Table 6](#tbls6){ref-type="table"}) (Dicko [@b6]).

###### Health system plus recipient-oriented interventions versus no intervention

The Banerjee [@b2] study provided low-certainty evidence that a multi-faceted intervention consisting of a health system (mobile immunisation camp) and recipient-oriented (non-monetary incentive) intervention may improve coverage for full vaccination (RR 6.66, 95% CI 3.93 to 11.28; [Analysis 5.1](#fig501){ref-type="fig"}; [Table 5](#tbls5){ref-type="table"}).

### Secondary outcomes

#### Proportion of children who received the vaccine under study

##### Recipient-oriented interventions versus usual care

###### Health education

Evidence-based discussions probably improve coverage of measles vaccine (RR 1.63, 95% CI 1.03 to 2.58; [Analysis 1.1](#fig101){ref-type="fig"}) (Andersson [@b1]). We also found low-certainty evidence that information campaigns (presentation of audiotape messages, and distribution of posters and leaflets in the community) may increase the coverage of at least one dose of a vaccine (RR 1.43, 95% CI 0.72 to 2.86; [Analysis 1.3](#fig103){ref-type="fig"}) (Pandey [@b11]).

##### Monetary incentives or disincentives versus no intervention

One study conducted in Mexico provided low-certainty evidence that monetary incentives may have little or no effect on measles vaccination coverage (RR 1.00, 95% CI 0.69 to 1.45; [Analysis 3.1](#fig301){ref-type="fig"}) (Barham [@b3]), and coverage of BCG vaccination according to schedule (RR 0.98, 95% CI 0.47 to 2.05; [Analysis 3.3](#fig303){ref-type="fig"}) (Barham [@b3]). However, the CI for BCG uptake included an important benefit. Morris [@b9] reported data on the impact of withdrawing monetary vouchers (a household-level monetary incentive) on the coverage of MMR and DTP1 vaccines. The study provided low-certainty evidence that withdrawing monetary vouchers may have little or no effect on coverage of MMR (RR 0.95, 95% CI 0.83 to 1.07; [Analysis 3.4](#fig304){ref-type="fig"}) and DTP1 (RR 1.09, 95% CI 0.94 to 1.28; [Analysis 3.5](#fig305){ref-type="fig"}).

##### Provider-oriented interventions versus usual care

Djibuti [@b7] provided low-certainty evidence that training immunisation managers to provide supportive supervision for health providers may have little or no effect on coverage for three doses of oral polio vaccine (OPV3), and three doses of hepatitis B virus (HBV3). The differences in coverage between the intervention and control groups were 8.4% (P value = 0.173) for OPV3 and 13.4% (P value = 0.172) for HBV3.

##### Health system interventions versus usual care

###### Home visits versus usual care

Brugha [@b5] assessed the effect of home visits on improving coverage for OPV3 and measles. This study provided low-certainty evidence that home visits may improve OPV3 (RR 1.22, 95% CI 1.07 to 1.39; [Analysis 4.1](#fig401){ref-type="fig"}; [Table 4](#tbls4){ref-type="table"}) and measles vaccine coverage (RR 1.26, 95% CI 1.08 to 1.46; [Analysis 4.2](#fig402){ref-type="fig"}).

##### Multi-faceted interventions

###### Integration of immunisation to other healthcare services versus standard care

There was low-certainty evidence that integrating immunisation services with intermittent prophylactic treatment of malaria in infants may improve measles vaccine coverage (RR 1.13, 95% CI 1.06 to 1.20; [Analysis 6.3](#fig603){ref-type="fig"}), but may have little or no effect on BCG coverage (RR 1.03, 95% CI 0.89 to 1.19; [Analysis 6.1](#fig601){ref-type="fig"}) (Dicko [@b6]).

###### Health system plus provider-oriented interventions versus standard care

One arm of the study by Morris [@b9] aimed to strengthen peripheral health services through training QA teams (provider package) and the provision of equipment, drugs, and materials (health system package) and also provided nutritional promotion. This arm of the intervention was not delivered as per protocol. There was low-certainty evidence that this intervention may lead to little or no difference in MMR coverage (RR 1.06, 95% CI 0.91 to 1.23; [Analysis 3.4](#fig304){ref-type="fig"}) and DTP1 coverage (RR 1.00, 95% CI 0.83 to 1.21; [Analysis 3.5](#fig305){ref-type="fig"}).

###### Health system plus provider-oriented plus participant-oriented interventions versus standard care

Another arm of Morris [@b9] evaluated a combination of monetary incentives (recipient-oriented); QA (provider-oriented); and provision of equipment, drugs, and materials (health system oriented interventions). The study provided low-certainty evidence that this intervention may lead to little or no difference in MMR coverage (RR 1.11, 95% CI 0.99 to 1.24; [Analysis 3.4](#fig304){ref-type="fig"}) and DPT1 coverage (RR 1.15, 95% CI 0.97 to 1.37; [Analysis 3.5](#fig305){ref-type="fig"}), though the CIs included important benefits.

#### Number of children under five years of age fully immunised with all scheduled vaccines

##### Monetary incentives

Robertson [@b12] and Maluccio [@b8] provide low-certainty evidence that monetary incentives may have little or no effect on coverage of all vaccines among children aged under five years (RR 1.05, 95% CI 0.90 to 1.23; [Analysis 3.2](#fig302){ref-type="fig"}; [Table 3](#tbls3){ref-type="table"}).

#### Occurrence of vaccine preventable diseases

None of the included studies provided data on the occurrence of the targeted diseases.

#### Costs of the intervention

Only one of the included studies estimated the costs of the intervention (Andersson [@b1]). This evaluation indicated that community-based health education cost USD9.00 per child.

#### Attitudes of carers and clients towards immunisation

None of the included studies provided data on the attitudes of caregivers and clients towards immunisation.

#### Adverse events following immunisation

None of the included studies reported data on AEFI.

Facility-based health education plus redesigned reminder card for improving childhood immunisation coverage
===========================================================================================================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- -------------------------- ----------------------------- ---------------------------------- --------------------
  **Population:** children aged 6 weeks\                                                                                                                                                                                                                                                                                                                        
  **Setting:** Pakistan\                                                                                                                                                                                                                                                                                                                                        
  **Intervention:** facility-based health education + redesigned reminder vaccination card\                                                                                                                                                                                                                                                                     
  **Comparison:** standard care                                                                                                                                                                                                                                                                                                                                 

  Outcomes                                                                                                                                                                                                                Anticipated absolute effects\* (95% CI)   Relative effect(95% CI)    No of participants(studies)   Certainty of the evidence(GRADE)   

  Standard care                                                                                                                                                                                                           Health education plus redesigned card                                                                                                 

  DTP3\                                                                                                                                                                                                                   470 per 1000                              705 per 1000(569 to 879)   RR 1.50(1.21 to 1.87)         1502(2 studies)^3^                 ⊕⊕⊖⊖ **low** ^1,2^
  (Follow-up: 90 days)                                                                                                                                                                                                                                                                                                                                          

  \***The effect in the \'health education + redesigned card\' group** (and its 95% CI) was based on the assumed risk in the \'standard care\' group and the **relative effect** of the intervention (and its 95% CI).\                                                                                                                                         
  **CI:** confidence interval;**DTP3:** 3 doses of diphtheria-tetanus-pertussis containing vaccines; **RR:** risk ratio.                                                                                                                                                                                                                                        

  **GRADE Working Group grades of evidence**\                                                                                                                                                                                                                                                                                                                   
  **High certainty:** This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different is low.\                                                                                                                                                                                               
  **Moderate certainty:** This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different is moderate.\                                                                                                                                                                                           
  **Low certainty:** This research provides some indication of the likely effect. However, the likelihood that it will be substantially different is high.\                                                                                                                                                                                                     
  **Very low certainty:** This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different is very high.\                                                                                                                                                                              
  \'Substantially different\' implies a large enough difference that it might affect a decision.                                                                                                                                                                                                                                                                
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- -------------------------- ----------------------------- ---------------------------------- --------------------

^1^ We rated down by 1 level because of unexplained heterogeneity of effects across studies; P value = 0.04; I^2^ = 77%.

^2^ We rated down by 1 level because we judged the 2 included studies at unclear risk of selection bias and at high risk of performance and detection bias.

^3^ Usman [@b13]; Usman [@b14].

Monetary incentives for improving childhood immunisation coverage
=================================================================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- -------------------------- ----------------------------- ---------------------------------- ------------------
  **Population:** children aged \< 5 years\                                                                                                                                                                                                                                                                                                     
  **Setting:** Nicaragua (1 study) and Zimbabwe (1 study)\                                                                                                                                                                                                                                                                                      
  **Intervention:** monetary incentives in the form of household cash transfers\                                                                                                                                                                                                                                                                
  **Comparison:** standard care                                                                                                                                                                                                                                                                                                                 

  Outcomes                                                                                                                                                                                                Anticipated absolute effects\* (95% CI)   Relative effect(95% CI)    No of participants(studies)   Certainty of the evidence(GRADE)   

  Standard care                                                                                                                                                                                           Monetary incentive                                                                                                                    

  Fully immunised children\                                                                                                                                                                               701 per 1000                              736 per 1000(631 to 862)   RR 1.05(0.90 to 1.23)         1000(2 studies)^2^                 ⊕⊕⊖⊖ **low** ^1^
  (Follow-up: 13 months to 5 years)                                                                                                                                                                                                                                                                                                             

  \***The effect in the \'monetary incentive\' group** (and its 95% CI) was based on the assumed risk in the \'standard care\' group and the **relative effect** of the intervention (and its 95% CI).\                                                                                                                                         
  **CI:** confidence interval; **DTP3:** 3 doses of diphtheria-tetanus-pertussis containing vaccines; **RR:** risk ratio.                                                                                                                                                                                                                       

  **GRADE Working Group grades of evidence**\                                                                                                                                                                                                                                                                                                   
  **High certainty:** This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different is low.\                                                                                                                                                                               
  **Moderate certainty:** This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different is moderate.\                                                                                                                                                                           
  **Low certainty:** This research provides some indication of the likely effect. However, the likelihood that it will be substantially different is high.\                                                                                                                                                                                     
  **Very low certainty:** This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different is very high.\                                                                                                                                                              
  \'Substantially different\' implies a large enough difference that it might affect a decision.                                                                                                                                                                                                                                                
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- -------------------------- ----------------------------- ---------------------------------- ------------------

^1^ We rated down by 2 levels because we judged the 2 included studies at high risk of bias.

^2^ Maluccio [@b8]; Robertson [@b12].

Home visits for improving childhood immunisation coverage
=========================================================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------- ---------------------------- ----------------------------- ---------------------------------- ------------------
  **Population: c**hildren aged 12-18 months\                                                                                                                                                                                                                                                                                              
  **Setting:** Ghana\                                                                                                                                                                                                                                                                                                                      
  **Intervention:** home visits\                                                                                                                                                                                                                                                                                                           
  **Comparison:** standard care                                                                                                                                                                                                                                                                                                            

  Outcomes                                                                                                                                                                                         Anticipated absolute effects\* (95% CI)   Relative effect(95% CI)      No of participants(studies)   Certainty of the evidence(GRADE)   

  Standard care                                                                                                                                                                                    Home visits                                                                                                                             

  **OPV3** (Follow-up: 6 months)                                                                                                                                                                   **73 per 100**                            **89 per 100** (76 to 100)   **RR 1.22** (1.07 to 1.39)    419(1 study)^2^                    ⊕⊕⊖⊖ **low** ^1^

  \***The effect in the \'home visits\' group** (and its 95% CI) was based on the assumed risk in the \'standard care\' group and the **relative effect** of the intervention (and its 95% CI).\                                                                                                                                           
  **CI:** confidence interval; **OPV3:** 3 doses of oral polio vaccine; **RR:** risk ratio.                                                                                                                                                                                                                                                

  GRADE Working Group grades of evidence\                                                                                                                                                                                                                                                                                                  
  **High certainty:** This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different is low.\                                                                                                                                                                          
  **Moderate certainty:** This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different is moderate.\                                                                                                                                                                      
  **Low certainty:** This research provides some indication of the likely effect. However, the likelihood that it will be substantially different is high.\                                                                                                                                                                                
  **Very low certainty:** This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different is very high.                                                                                                                                                          
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------- ---------------------------- ----------------------------- ---------------------------------- ------------------

^1^ We rated down by 2 levels because the 1 included study was judged to be at high risk of bias.

^2^ Brugha [@b5].

Immunisation outreach with and without incentives for improving childhood immunisation coverage
===============================================================================================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- -------------------------- ----------------------------- ---------------------------------- ------------------
  **Population:** children aged 0-6 months\                                                                                                                                                                                                                                                                                                        
  **Setting:** India\                                                                                                                                                                                                                                                                                                                              
  **Intervention:** regular immunisation outreach with or without household incentives\                                                                                                                                                                                                                                                            
  **Comparison:** standard care                                                                                                                                                                                                                                                                                                                    

  Outcomes                                                                                                                                                                                                   Anticipated absolute effects\* (95% CI)   Relative effect(95% CI)    No of participants(studies)   Certainty of the evidence(GRADE)   

  Standard care                                                                                                                                                                                              Immunisation outreach                                                                                                                 

  Fully immunised - regular immunisation outreach only\                                                                                                                                                      58 per 1000                               180 per 1000(98 to 330)    RR 3.09(1.69 to 5.67)         1239(1 study)^2^                   ⊕⊕⊖⊖ **low** ^1^
  (Follow-up: 18 months)                                                                                                                                                                                                                                                                                                                           

  Fully immunised - regular immunisation outreach + non-monetary incentive\                                                                                                                                  58 per 1000                               387 per 1000(228 to 656)   RR 6.66(3.93 to 11.28)        1242(1 study)^2^                   ⊕⊕⊖⊖ **low** ^1^
  (Follow-up: 18 months)                                                                                                                                                                                                                                                                                                                           

  \***The effect in the \'immunisation outreach\' group** (and its 95% CI) was based on the assumed risk in the \'standard care\' group and the **relative effect** of the intervention (and its 95% CI).\                                                                                                                                         
  **CI:** confidence interval; **RR:** risk ratio.                                                                                                                                                                                                                                                                                                 

  **GRADE Working Group grades of evidence**\                                                                                                                                                                                                                                                                                                      
  **High certainty:** This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different is low.\                                                                                                                                                                                  
  **Moderate certainty:** This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different is moderate.\                                                                                                                                                                              
  **Low certainty:** This research provides some indication of the likely effect. However, the likelihood that it will be substantially different is high.\                                                                                                                                                                                        
  **Very low certainty:** This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different is very high.\                                                                                                                                                                 
  \'Substantially different\' implies a large enough difference that it might affect a decision.                                                                                                                                                                                                                                                   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- -------------------------- ----------------------------- ---------------------------------- ------------------

^1^ We rated down by 2 levels because we judged the 1 included study at high risk of bias.

2 Banerjee [@b2].

Integration of immunisation with other health services for improving childhood immunisation coverage in low- and middle-income countries
========================================================================================================================================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------- ---------------------------- ----------------------------- ---------------------------------- ------------------
  **Population:** children aged 0-23 months\                                                                                                                                                                                                                                                                                               
  **Setting:** Mali\                                                                                                                                                                                                                                                                                                                       
  **Intervention:** integration of immunisation services with intermittent preventive treatment of malaria\                                                                                                                                                                                                                                
  **Comparison:** standard care                                                                                                                                                                                                                                                                                                            

  Outcomes                                                                                                                                                                                         Anticipated absolute effects\* (95% CI)   Relative effect(95% CI)      No of participants(studies)   Certainty of the evidence(GRADE)   

  Standard care                                                                                                                                                                                    Integration                                                                                                                             

  DTP3\                                                                                                                                                                                            602 per 1000                              1000 per 1000(854 to 1000)   RR 1.92(1.42 to 2.59)         1481(1 study)^2^                   ⊕⊕⊖⊖ **low** ^1^
  (Follow-up: 12 months)                                                                                                                                                                                                                                                                                                                   

  \***The effect in the \'integration\' group** (and its 95% CI) was based on the assumed risk in the \'standard care\' group and the **relative effect** of the intervention (and its 95% CI).\                                                                                                                                           
  **CI:** confidence interval; **DTP3:** 3 doses of diphtheria-tetanus-pertussis containing vaccines; **RR:** risk ratio.                                                                                                                                                                                                                  

  **GRADE Working Group grades of evidence**\                                                                                                                                                                                                                                                                                              
  **High certainty:** This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different is low.\                                                                                                                                                                          
  **Moderate certainty:** This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different is moderate.\                                                                                                                                                                      
  **Low certainty:** This research provides some indication of the likely effect. However, the likelihood that it will be substantially different is high.\                                                                                                                                                                                
  **Very low certainty:** This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different is very high.\                                                                                                                                                         
  \'Substantially different\' implies a large enough difference that it might affect a decision.                                                                                                                                                                                                                                           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------- ---------------------------- ----------------------------- ---------------------------------- ------------------

^1^ We rated down by 2 levels because we judged the 1 included study at high risk of bias.

2 Dicko [@b6].

Discussion
==========

Summary of main results
-----------------------

Ten cluster RCTs and four individually randomised controlled trials met our inclusion criteria. These were conducted in Georgia, Ghana, Honduras, India, Mali, Mexico, Nepal, Nicaragua, Pakistan, and Zimbabwe. The interventions evaluated in the studies included community-based health education, facility-based health education, home visits, household monetary incentives, and integration of immunisation services to intermittent preventive treatment of malaria. These were implemented either as single interventions or as multi-faceted interventions.

We found moderate-certainty evidence that giving information and discussing vaccination with parents and other community members at village meetings or at home probably improve immunisation coverage. We also found low-certainty evidence that giving information to parents about the importance of vaccinations during visits to health clinics combined with specially designed \'reminder-type\' immunisation cards may improve immunisation coverage. There was low-certainty evidence that regular immunisation outreach, home visits, and integration of immunisation with other primary healthcare services (such as intermittent preventive treatment of malaria) may improve immunisation coverage. However, there was currently low-certainty evidence that household monetary incentives (in the form of conditional or unconditional cash transfers) may have little or no effect on immunisation coverage.

Overall completeness and applicability of evidence
--------------------------------------------------

In the context of the GVAP, there is an urgent need for effective interventions that would ensure equitable uptake of existing vaccines by people in all communities around the world (WHO [@b135]). However, immunisation coverage remains uneven between and within the world\'s regions and countries. For example, in 2014, DTP3 coverage was 96% in Europe and the Western Pacific and only 77% in sub-Saharan Africa (WHO [@b137]). The GVAP coverage target was to achieve DTP3 coverage of 90% in all countries by 2015; but only 129 (66%) countries have achieved this coverage target. The 10 countries with the largest numbers of unimmunised children are all low-income or lower- to middle-income countries (SAGE [@b129]).

Barriers to improving immunisation coverage could be broadly categorised into factors that affect the demand for vaccines, barriers to the supply of vaccines, or both (Lewin [@b114]). Around 2014, the concept of vaccine hesitancy emerged as a factor hindering the demand of vaccines (Larson [@b111]). The Strategic Advisory Group of Experts on immunisation identified factors that influence vaccine hesitancy. These were grouped into three major areas, namely contextual influences, vaccine and vaccination specific issues, and individual and social group influences. The influences of these factors are said to be complex and context-specific, varying in time, place, and vaccine (Larson [@b111]). It is unclear if the interventions tested in the included studies were derived from identified barriers in the settings, though specific concepts were tested. In general, though, interventions to improve coverage should focus on identified barriers within settings.

The included studies evaluated interventions that varied enormously in content and in the intensity of delivery, raising questions regarding the likely impact of interventions in different settings and regarding how best to implement the interventions. For instance, how effective will a three-minute health education intervention (Usman [@b13]; Usman [@b14]; low-certainty evidence) be in a typical clinical setting in improving completion of the immunisation schedule? Will the same effect be obtained for more than one vaccine? How feasible is evidence-based discussion (Andersson [@b1]; moderate-certainty evidence) in a community with low literacy? How feasible is a monetary incentive intervention (Morris [@b9]; low-certainty evidence) in a resource-poor setting without donor support? The limited number of studies makes it difficult to explore these issues and restricts the wider applicability of the evidence.

Home visits to promote childhood vaccination uptake or to deliver vaccination are common in many settings. The applicability of the home visit intervention as implemented in Brugha [@b5] may be affected by several factors. First, the use of first-degree university students as lay/community health workers to deliver this type of intervention may not be feasible in many resource-poor settings. Two reviews reported moderate-certainty evidence on the effectiveness of lay health workers in promoting the uptake of childhood immunisation services (Glenton [@b98]; Lewin [@b113]). In these reviews, the level of education of the lay health workers varied from primary school graduates to high school graduates, with some studies not reporting this information. Furthermore, the settings of the studies were middle- and high-income countries. Second, referring caregivers of children who need immunisation to a health facility requires that there be a facility within reasonable distance of the community. This type of intervention may not be useful in settings in which households do not have easy access to health facilities. Finally, administering injectable vaccines at home has implications for vaccine quality and injection safety; given the need to maintain the cold chain from manufacture to administration of vaccines as well as the need to dispose of injection material safely (preferably by incineration). This approach may not be cost effective or sustainable in a resource-constrained economy. The high diversity of the interventions and the contextual differences, therefore, make it difficult to draw conclusion on their effectiveness in improving vaccination coverage.

There is paucity of data on the sustainability of the interventions presented in this review, as none of the included studies reported long-term follow-up data. All had two data points that were at baseline and post-intervention, making it impossible to ascertain the long-term effects of the interventions. However, two studies aimed to build the capacity of the providers (Djibuti [@b7]; Morris [@b9]), and to upgrade the physical structure (Morris [@b9]). These strategies can contribute to sustainability if other supporting resources are available. A sustainability framework for projects aimed at strengthening immunisation systems in LMICs should include maintenance or continuance of health benefits from projects, institutionalisation of projects within the system, and capacity development (Gruen [@b99]; [@b131]). It has been observed that for a programme to be sustained, early and active planning is required ([@b131]). Sustainability of quality improvement interventions has been particularly challenging in LMICs, especially when a programme is supported by external funds (Gruen [@b99]). Withdrawal of external funds may not only impact negatively on the gains of the programme but may jeopardise support for future programmes (Gruen [@b99]). This is particularly so when the intervention is cost intensive.

Information on the resource implications of interventions may be helpful in determining their long-term sustainability and cost effectiveness. Only one study provided data on the cost of the intervention (Andersson [@b1]). This study reported that community-based health education in Pakistan costs USD9.00 per child. The cost of interventions would depend on the context of the intervention, as the cost to vaccinate a child fully has been reported to vary between USD1 and USD40 in LMICs (Shea [@b130]). Therefore, the cost of interventions should be reviewed within the context and settings of the studies. As part of their systematic review on the effects of lay or community health workers in primary health care (Glenton [@b98]; Lewin [@b113]), Glenton and colleagues reviewed the costs and cost-effectiveness of vaccination programme interventions involving lay health workers (Corluka [@b90]). The authors found that studies did not adequately address affordability and sustainability and were also highly heterogeneous in terms of settings and outcomes, limiting their comparability. In addition, they found insufficient data to allow any conclusions to be drawn regarding the cost-effectiveness of lay health worker interventions to promote vaccination uptake. Studies focused largely on health outcomes and did illustrate to some extent how the institutional characteristics of communities, such as governance and sources of financial support, influence sustainability (Corluka [@b90]). Considering that the interventions assessed in this review were set up as parallel programmes, rather than being integrated into routine services, it is unclear how effective they will be if integrated with other services within the system, with the typical levels of human and other resources available. This calls for cost-effectiveness evaluations of these interventions, particularly as integrated rather than stand-alone programmes (Dicko [@b6]; [@b123]). Such evaluations also have limitations as it can be difficult to translate these findings from one setting to another. Therefore, there is need for study authors to provide the details of the required resources to implement the intervention.

Many immunisation programmes in LMICs are delivered as mass immunisation on set \'immunisation days\', following mass immunisation campaigns (Balraj [@b21]; Bandyopadhyay [@b22]; Berry [@b27]; Cutts [@b32]; Gomber [@b38]; Kumar [@b45]; Lin [@b47]; Linkins [@b48]; Shaikh [@b61]). None of the reports of this commonly used strategy met the criteria for inclusion in our review or for the Saeterdal [@b128] Cochrane review on interventions aimed at communities to inform and /or educate on early childhood vaccination. Shea [@b130] has noted that it may be difficult to randomise mass media interventions. However, ITS designs could be used to assess the effects of these mass immunisation campaigns on immunisation coverage (Nglazi [@b121]).

Quality of the evidence
-----------------------

This review included 14 studies, three had unclear risk of bias (Andersson [@b1]; Owais [@b10]; Pandey [@b11]), while all the others had high risk of bias. The main study limitations were non-concealment of allocation, no blinding, lack of protection against contamination, and extraneous sources of bias. The cluster RCTs were adjusted for cluster effects. Overall, the certainty of the evidence for most interventions was low. This implies that the currently available research provides some indication of the likely effect of the interventions. However, the likelihood is high that the true effect of the interventions will be substantially different.

Potential biases in the review process
--------------------------------------

We minimised bias in the process of conducting and reporting the current review by adhering to standard Cochrane guidelines (Higgins [@b102]). However, access to studies from LMICs is limited to those studies published in indexed journals. There may be a need to identify non-indexed local journals and the grey literature in low-income countries, and to conduct handsearching of these sources. In addition, as noted by Machingaidze and colleagues, due to the broad nature of childhood immunisation (encompassing many different components) identifying a search strategy that includes all aspects of childhood immunisations is challenging (Machingaidze [@b118]). However, in one 2014 Cochrane review on community-aimed interventions to inform and educate about childhood vaccination, the authors did not identify additional studies to those included in this review (Saeterdal [@b128]).

Agreements and disagreements with other studies or reviews
----------------------------------------------------------

Several previous systematic reviews assessed the effectiveness of interventions for improving childhood immunisation coverage (Batt [@b82]; Bordley [@b85]; Giles [@b96]; Glenton [@b98]; Jacobson [@b103]; Johri [@b105]; Kaufman [@b107]; Kendrick [@b108]; Pegurri [@b124]; Ryman [@b127]), although very few of them included studies from LMICs (Batt [@b82]; Glenton [@b98]; Pegurri [@b124]; Ryman [@b127]), and many were already out-of-date as the dates of the most recent searches for the reviews were pre-2005 (Batt [@b82]; Bordley [@b85]; Jacobson [@b103]; Kendrick [@b108]; Pegurri [@b124]).

Measures of effect for participant reminders in this review tend to agree with a now out-of-date systematic review of interventions aimed at reminding people of their immunisation schedules (Jacobson [@b103]). Home visits, participant reminders through a redesigned immunisation card, and health education improved the uptake of immunisation in this review. Similarly, telephone calls, sending of letters and postcards, and speaking to clients in person improved the coverage of childhood vaccines in the participant-reminder review (Jacobson [@b103]).

We found low-certainty evidence that monetary incentives (in the form of vouchers, conditional, and unconditional cash transfers) may have little or no effect on uptake of vaccines. This differs from the findings of several related systematic reviews: one systematic review on the effect of conditional cash transfers on health outcomes and the use of health services reported an improvement in the use of health services but, similar to this review, reported mixed results for uptake of immunisation in children (Lagarde [@b109]). Two older (and now out of date) reviews also reported on the effects of this intervention (Giuffrida [@b97]; Kane [@b106]). One more recent review on the topic included 16 studies from high-income countries on smoking cessation (10 studies), attendance for vaccination or screening (five studies), and physical activity (one study) (Giles [@b96]). It reported an increase in vaccination and screening attendance with monetary incentives. However, subgroup analysis showed that cash plus other motivational components was more effective than cash or vouchers alone. The differences between our review findings and those of this review may reflect differences across settings (high-income compared to low- and middle-income countries) or limitations of the studies included in our review. In addition, the Morris [@b9] study findings were of low certainty because of high risk of bias.

Ryman and colleagues conducted a comprehensive search in 2005 to identify peer-reviewed and grey literature on strategies for improving childhood immunisation coverage in LMICs (Ryman [@b127]). They identified 25 studies that included an appropriate control group, and grouped the papers into four strategic approaches: bringing immunisation closer to communities (11 studies), using information dissemination to increase demand for vaccination (three studies), changing practices in fixed sites (four studies), and using innovative management practices (seven studies). The studies included RCTs, nRCTs, CBAs, and observational studies, and reported improvements in immunisation coverage of varying degrees. Unlike Ryman and colleagues, we excluded observational studies. We included CBAs if they had more than two units in both the intervention and control groups, in accordance with EPOC guidance (EPOC [@b93]). Though the Ryman review identified studies that reported improvements in immunisation coverage, they noted that the indicators of success varied widely making it impossible for the data to be merged in a meta-analysis (Ryman [@b127]). We also found that studies reported immunisation outcomes in a variety of ways, for example, proportion of children aged 12 to 23 months who had received measles, proportion of children aged 12 to 23 month who had received full course of DTP (Andersson [@b1]); probability of receiving at least one immunisation (excluding OPV), the presence of the BCG scar, the number of immunisations received, the probability of being fully immunised (Banerjee [@b2]); immunisation full coverage of children aged 12 to 23 months with three doses of DTP, BCG, and measles vaccines (Barham [@b3]); DTP3 coverage at the end of day 90 post-enrolment (Usman [@b14]), etc. However, our foreknowledge of childhood immunisation programmes guided our decisions regarding which outcomes were synonymous (and thus can be combined in a meta-analysis) and which are not.

In a related systematic review, Glenton and colleagues assessed the effects of lay or community health worker interventions on childhood immunisation coverage (Glenton [@b98]). They conducted the last search in 2009, and identified 12 studies; including 10 RCTs. Five of the studies were carried out in LMICs. In 10 studies, community health workers promoted childhood immunisation and in the remaining two studies, community health workers vaccinated children themselves. Most of the studies showed that the use of lay or community health workers to promote immunisation uptake probably increased the number of children who were fully immunised. Our findings on the effect of community-based health education and home visits were consistent with these findings.

Johri and colleagues reported a systematic review of \"strategies to increase demand for vaccination are effective in increasing child vaccine coverage in low- and middle-income countries\". The authors concluded that, \"demand-side interventions are effective in improving the uptake of childhood vaccines delivered through routine immunization services in low- and middle-income countries\" (Johri [@b105]).

Finally, our review is related to two other Cochrane reviews (Kaufman [@b107]; Saeterdal [@b128]); conducted under the auspices of the \'Communicate to Vaccinate\' project (Lewin [@b114]). Kaufman [@b107] assessed the effects of face-to-face interventions for informing or educating parents about early childhood vaccination on immunisation uptake and parental knowledge and Saeterdal [@b128] reviewed interventions aimed at communities to inform or educate (or both) about early childhood vaccination. The two reviews included studies from any setting while this review focused on low LMICs. We included three of the studies (Bolam [@b4]; Usman [@b13]; Usman [@b14]) included in the Kaufman [@b107] review in our review and two studies (Andersson [@b1]; Pandey [@b11]) from our review were included in the Saeterdal [@b128] review. While the findings of this review were similar to the findings of the Saeterdal [@b128] review (i.e. that these interventions probably increase immunisation coverage), they differed from the findings of Kaufman [@b107] that reported little or no improvement in immunisation coverage. This may be because Kaufman included studies from high-, middle-, and low-income countries.

Authors\' conclusions
=====================

Implications for practice
-------------------------

Barriers to immunisation uptake are context related. For any intervention to be adopted in a setting it must be designed to meet the peculiar needs of the setting and in the magnitude that best addresses the needs. Studies included in this review tested general concepts that were not linked with identified needs or barriers in the study settings. In addition, the certainty of evidence of the included studies was mostly low. This infers that even within the same setting, the likelihood of the observed effect being substantially different is high. In one systematic review to identify determinants of vaccine hesitancy in different settings, including their context-specific causes, expression, and impact, Larson [@b111] reported that these factors could not be considered in isolation as there were multiple influences at play. Further, individual factors may have conflicting effects even in the same setting. For instance, low-income status was both a promoter and a barrier to vaccination in Nigeria. As a barrier it was linked with access and low education. Adopting interventions without considering other confounding factors may produce little or no effect, as this review demonstrated.

This review showed that evidence-based discussion that aims at knowledge translation to community members may be more effective than conventional health education strategies. However, it has been observed that interventions such as community meetings may be cost intensive and so should be adopted with caution (Saeterdal [@b128]). Health system interventions such as home visits and regular immunisation outreach sessions are likely to be useful for difficult-to-reach communities though there were no data to assess the cost of their implementation. Overall, the magnitude of effect of these interventions is small and sustainability over long periods is uncertain. Participant reminder interventions have consistently shown improvement in vaccination in this review from studies in low-and middle-income countries and in another review from high-income countries (Jacobson [@b103]). Therefore, it may be possible to adapt this intervention to suit different settings. There is low-certainty evidence that monetary incentives have little or no effect on immunisation uptake. Another review suggested that such incentives may fail to improve coverage when other barriers to immunisation exist (Lagarde [@b109]). The affordability and sustainability of incentives is uncertain in low- and middle-income countries, particularly when supported by external funds. Implementation, particularly in low- and middle-income countries, may, therefore, need to be accompanied by rigorous evaluation.

Implications for research
-------------------------

Despite the vast investment of resources in improving vaccination coverage in low- and middle-income countries few studies, and only low- to moderate-certainty findings, are available to inform policy and decision making on vaccination in these settings. The certainty of the existing evidence implies that the likelihood is high that the true effect of the interventions will be substantially different. Therefore, this review suggests that more rigorous studies are required to evaluate:

participant reminder and recall interventions that are adaptable to low- and middle-income countries as this approach has been shown to be effective in high-income countries;community-based health education strategies, including mass campaigns, as these interventions may be more effective than facility-based health education;provider-oriented and multi-faceted interventions (e.g. reaching every district strategy) for improving childhood immunisation coverage in low- and middle-income countries;regulation to make vaccination a requirement for school entry, and, therefore, increase vaccination coverage;incentives for vaccination providers;plans of action for immunisation coverage and disease reduction.

These studies may also need to include:

measures of sustainability such as integration into routine immunisation services, long-term impact of the interventions, and incidence of targeted diseases;Cost-effectiveness of various interventions and resource use and unit costs for vaccination for different strategies.

These studies should be based on factors influencing vaccination uptake within specified context, identified from qualitative studies, to aid translatability to similar contextual settings. Larson [@b111] has identified the paucity of qualitative data as a setback to identifying how factors associated with vaccine hesitancy interact with one another.
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Characteristics of studies
==========================

Characteristics of included studies \[ordered by study ID\] {#sec03}
-----------------------------------------------------------

###### 

Andersson 2009

  ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Cluster RCT in Pakistan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Participants                                                  Setting: Lasbela, 1 of the poorest districts in Balochistan Province in Pakistan.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                Aim: authors hypothesised that if the community accessed information on the cost-benefits of immunisation, the uptake of vaccines would improve without requiring improvement in service delivery\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                Participants: 180 community groups with each group having 8-10 participants, both male and female. Outcome measured in children aged 12-23 months; 911 children at pre-intervention and 956 at post-intervention                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Interventions                                                 **Intervention:***evidence-based discussion on immunisation in 18 clusters:* trusted members of the committee were selected for a 3-phased discussion. 9 field teams (facilitators) had discussion with 180 community groups of 8-10 members each in 94 villages for the intervention group. 3 phases of discussion were held with the community groups. First phase the community groups discussed the situation of child immunisation in the union council, the smallest unit of the local government system. Facilitators discussed the risk of non-vaccination for measles with the community groups. Second phase, discussed cost-benefits of vaccination and treatment of measles. Third stage featured discussion on challenges of immunisation and identification of barriers and plans of action to increase access for immunisation services and means of spreading the discussion on vaccination\   
                                                                **Control:** usual care in 14 clusters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Outcomes                                                      Proportion of 12-23 month olds who had received measles vaccination\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                Proportion of 12-23 month olds who had received full course of DPT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Duration of intervention                                      August 2006 to May 2007 (9 months)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Notes                                                         Follow-up after 1 year (baseline conducted in spring 2005; follow-up spring 2007)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Random number generator allocated baseline communities to 18 intervention enumeration areas and 14 control enumeration areas

  Allocation concealment (selection bias)                       Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sequence concealed and intervention assigned centrally

  Blinding (performance bias and detection bias) All outcomes   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Interviewers did not know which clusters had received the intervention, only the field co-ordinator knew

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Not applicable. Samples taken pre- and post-intervention

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Unclear what outcomes were stated in the protocol

  Other bias                                                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \"Although the facilitators discussed with participants their plans for disseminating the discussions within their communities, the intervention did not make special provision for the participants to \'take back\' the discussion to others in the community, relying rather on endogenous networks for the information spill over.\" In addition, use of mothers\' recall for immunisation uptake may under estimate vaccine coverage\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Unit of study was enumeration area, analysis done at participant level; no adjustment for cluster effect

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Yes

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Baseline characteristics similar except, \"mothers willing to travel to vaccinate\", which was higher in the intervention than the control group

  Adequate protection against contamination?                    Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Measure to prevent contamination not stated
  ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Banerjee 2010

  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Cluster RCT in India                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Participants                                                  Setting: disadvantaged rural community in Udiapur, India with 2% immunisation coverage\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                Aim: to test the effect of reliable supply of free immunisation services and incentive to improve vaccine demand in a resource-poor setting\                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                Participants: 1640 children aged 0-6 months at baseline or 1-3 years at the endpoint survey                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Interventions                                                 **Intervention A:** once monthly reliable immunisation camp without incentive (379 children from 30 villages at endpoint). Intervention focused on establishing regular availability of immunisation services. Consisted of a mobile immunisation team, including a nurse and assistant, who conducted monthly immunisation camps in the villages. Camp held on a fixed date every month at a fixed time (11 am to 2 pm). Presence of nurse and assistant verified by requirement of timed and dated pictures of them in the villages and by regular monitoring\                      
                                                                **Intervention B:** once monthly reliable immunisation camp with small incentives consisting of raw lentils and metal plates for completion of schedule (382 children from 30 villages at endpoint). Intervention used the same infrastructure as intervention A but in addition offered parents 1 kg of raw lentils per immunisation administered and a set of \"thalis\" (metal plates used for meals) on completion of a child\'s full immunisation. Value of the lentils about USD1, equivalent to three-quarters of 1 day\'s wage, and the value of the \"thalis\" about USD2\   
                                                                **Control:** no intervention (860 children in 74 villages at endpoint)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Outcomes                                                      Probability of receiving at least 1 immunisation (excluding OPV, which almost all children received)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                Presence of the BCG scar\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                Number of immunisations received\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                Probability of being fully immunised. A fully immunised child received all the vaccines in the EPI schedule (1 dose of BCG, 3 doses of DTP, 3 doses of OPV, and 1 dose of measles vaccine) by the age of 1 year                                                                                                                                                                                                                                                                                                                                                                       

  Duration of intervention                                      18 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Notes                                                         Study conducted in rural state of Rajasthan, India                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \"Using the random number generator in the statistical package Stata (version 9), and after stratification by geographical block (the administrative unit above the village), one author (ED) randomly selected 30 of the 134 study villages to receive intervention A and 30 to receive intervention B. The 74 remaining villages were control villages and received no additional intervention\"

  Allocation concealment (selection bias)                       Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \"Within each village, a household census was conducted, and 30 households containing children aged 0-5 years were randomly selected with a random number generator to be part of the sample. The same households were surveyed again at the end point. The criterion for inclusion of a child in this study was to belong to a sampled household and to be aged 1-3 at the end point of the study (main sample) or to have been aged 0-6 months at baseline (baseline cohort)\"

  Blinding (performance bias and detection bias) All outcomes   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \"The allocation of villages to treatment or control was not blind\... Surveys were undertaken in randomly selected households at baseline and about 18 months after the interventions started (end point)\... Interviewers did not know which villages belonged to which intervention (or control) group\"

  Incomplete outcome data (attrition bias) All outcomes         High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Households lost between baseline and endpoint: 16% (71/453) in intervention A group, 17% (72/481) in intervention B group, and 17% (210/1224) in control group; 17% (363/2158) overall

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Protocol not available

  Other bias                                                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              None

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Yes

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Yes

  Adequate protection against contamination?                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \"Villages from all three treatment groups were sufficiently far from each other (over 20 km) so we expected no contamination between the villages\"
  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Barham 2005

  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------
  Methods                                                       Cluster RCT in Mexico                                                                                                                                                                                                                                                                                                                                                                                

  Participants                                                  Setting: Nicaragua, Mexico with immunisation rate = 90%\                                                                                                                                                                                                                                                                                                                                             
                                                                Participants: 506/50,000 eligible villages randomly chosenIntervention groups: selected from 320 communitiesControl group: selected from 186 communitiesValue of the transfers: USD25, adding 20-30% to the household income                                                                                                                                                                         

  Interventions                                                 Intervention: 2 cash transfers every 2 months; 1 general and 1 depending on school attendance nutrition component: food supplements for children aged 4-23 months, under-weight children aged 2-4 years, and pregnant and lactating women in beneficiary householdshealth component: regular healthcare appointments in health centres for the whole familyeducation component Control: Usual care   

  Outcomes                                                      Immunisation full coverage of children aged 12-23 months with 3 doses of DPT, BCG, and measles vaccines                                                                                                                                                                                                                                                                                              

  Duration of intervention                                      12-35 months                                                                                                                                                                                                                                                                                                                                                                                         

  Notes                                                         The controls should originally have acted as controls for 2 years, but for political reasons intervention in control communities occurred in late 1999 so only 18 months of comparison was possible and the control communities were, therefore, considered as cross-over intervention communities after 1 year of observation                                                                       

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                  Support for judgement

  Random sequence generation (selection bias)                   Unclear risk                                                                                                                                                                                                                                                                                                                                                                                         Method of randomisation not stated

  Allocation concealment (selection bias)                       High risk                                                                                                                                                                                                                                                                                                                                                                                            Not stated

  Blinding (performance bias and detection bias) All outcomes   High risk                                                                                                                                                                                                                                                                                                                                                                                            Study was not blinded

  Incomplete outcome data (attrition bias) All outcomes         Unclear risk                                                                                                                                                                                                                                                                                                                                                                                         Not applicable

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                         Study protocol not seen

  Other bias                                                    Unclear risk                                                                                                                                                                                                                                                                                                                                                                                         Not stated

  Baseline outcome measurements similar?                        High risk                                                                                                                                                                                                                                                                                                                                                                                            Baseline level of vaccination rate lower in treatment group

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                             Yes

  Adequate protection against contamination?                    Unclear risk                                                                                                                                                                                                                                                                                                                                                                                         Protection against contamination not stated.
  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------

###### 

Bolam 1998

  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       RCT in Nepal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Participants                                                  Setting: main maternity hospital in Kathmandu, Nepal\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                Aim: tested the effectiveness of 1-to-1 health education with perinatal mothers in a hospital setting in Nepal on infant care and family planning\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                Participants: 540 post-partum women                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Interventions                                                 **Intervention A:** 20 minute, 1-to-1 health education immediately after birth and 3 months later\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                **Intervention B:** 20 minute, 1-to-1 health education at birth only\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                **Intervention C:** 20 minute, 1-to-1 health education at 3 months only\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                **Intervention D:** control (no individual health education)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Outcomes                                                      Duration of exclusive breastfeeding\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                Appropriate immunisation of infant\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                Knowledge of oral rehydration solution and need to continue breastfeeding in diarrhoea\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                Knowledge of infant signs suggesting pneumonia\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                Uptake of postnatal family planning                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Duration of intervention                                      20-minute, individual health education at birth and 3 months later. Outcomes assessed at 3 and 6 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Notes                                                         First education session conducted in quiet room before discharge from hospital. Second education session conducted in the mothers\' home 3 months after delivery. Although the health education given at birth and 3 months covered broadly the same areas, more emphasis was placed on the importance of exclusive breastfeeding in the first session and on the need for family planning in the second session. Topics covered were infant feeding, treatment of diarrhoea, recognition of and response to symptoms suggesting acute respiratory infection in young infants, importance of immunisation, and importance of contraception after the puerperium. At the end of each session, health educator repeated the key messages covered and asked mother if she had any other questions   

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \"Restricted randomisation was used in blocks of 20, each block consisting of a random ordering of the numbers 0­19. Numbers 0­4, 5­9, 10­14, and 15­19 were assigned to groups A to D respectively\"

  Allocation concealment (selection bias)                       Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \"Timing of assignment was when a mother was identified by the research team either in labour or shortly after delivery. The details of allocation to groups for consecutively recruited mothers were in sealed envelopes\... The generator of the assignment was not involved in the execution of the allocation\"

  Blinding (performance bias and detection bias) All outcomes   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \"The mothers recruited and the health educators were not blind to the assignment of mothers to different groups. The outcome assessors were always blind to the assignment at both the 3 and 6 month follow up visits. Staff who were involved in data collection at the 3 month follow up were not involved in data collection at 6 months. The data analysts were not blind to the coding of the groups\"

  Incomplete outcome data (attrition bias) All outcomes         High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Each of the 4 groups (A-D) had 135 women. At 6 months, percentage of women lost-to-follow-up was 29% in group A, 21% in B, 26% in C, and 24% in D

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Protocol not available

  Other bias                                                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         None

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Not applicable

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Yes

  Adequate protection against contamination?                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Yes
  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Brugha 1996

  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Matched and cluster RCT in Ghana                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Participants                                                  Setting: urban settings in Ghana with regular immunisation services\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                Aim: addressing low immunisation coverage in spite of developed immunisation infrastructure\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                Participants: children aged 12-18 months. Included 200 mother-and-child pairs in the intervention group and 219 in the control group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Interventions                                                 **Intervention:***home visits in 30 clusters.* During home visits, interviewers (university students) administered questionnaires to mothers or female caregivers and fathers or male caregivers of children aged 12-18 months. Immunisations recorded from road-to-health card or clinic record (if card was missing) in a register. All respondents advised to bring identified children who had not completed immunisation schedule to the clinic for immunisation. A referral note was given to each child to bring to the clinic. Children who failed to complete immunisation were identified from the register and a maximum of 3 home visits made to each child within 6 months\   
                                                                **Control:** standard care in 30 clusters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Outcomes                                                      Completion of polio1, OPV3, and measles\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                Completion of schedule                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Duration of intervention                                      6 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Notes                                                         6 months of follow-up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Support for judgement

  Random sequence generation (selection bias)                   Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \"Contiguous clusters were paired, as far as possible within enumeration areas, and one of each pair of clusters was randomly chosen for the survey\...\"

  Allocation concealment (selection bias)                       Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Unclear 

  Blinding (performance bias and detection bias) All outcomes   High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Neither the provider nor the child was blinded

  Incomplete outcome data (attrition bias) All outcomes         Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Lost to follow-up not accounted for

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Unclear what outcomes were stated in protocol

  Other bias                                                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Children in registered and unregistered houses included in intervention group but only children in registered houses included in control group \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Analysis done at cluster level; also took matching into account at analysis

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Baseline immunisation coverage in the 2 groups were not statistically significant

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Yes

  Adequate protection against contamination?                    Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Though \"contiguous clusters were paired as far as possible within the enumeration area\", it was unclear if they were protected from contamination
  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Dicko 2011

  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Cluster RCT in Mali                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Participants                                                  Setting: Kolokani, a district in Mali hyperendemic for malaria and with immunisation level \< 50%\                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                Participants: children aged 0-23 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Interventions                                                 **Intervention:** intermittent preventive treatment of malaria in infants (in 11 clusters), i.e. administration to infants of ½ tablet of sulphadoxine-pyrimethamine along with EPI vaccines (DTP2, DTP3 and measles/yellow fever vaccine). Communities leaders were sensitised and health staff were trained. Supports for child health interventions were modified to allow the recording of the administration of the sulphadoxine-pyrimethamine along with EPI vaccines and the health interventions\           
                                                                **Control:** standard care in 11 clusters                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Outcomes                                                      Proportion of 9-23 months old children completely immunised with BCG, 3 doses of DTP, 1 dose of measles, and yellow fever vaccines                                                                                                                                                                                                                                                                                                                                                                                  

  Duration of intervention                                      12 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Notes                                                         Study conducted from December 2006 to December 2007. Sample size for the baseline survey estimated using the following assumptions. Based on a precision of 6% and alpha error of 5% and DTP3 coverage of two-thirds (67%), a sample of 472 children was selected using a cluster effect of 2. This sample size was doubled to take into account analysis for specific age categories and increased by 10% to take into account missing information, making a total sample size of 1050 children aged 0-23 months   

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Simple balloting. \"The health areas were numbered from 1 to 22 and each number was written on piece of paper that was folded. The 22 pieces of paper were then mixed and placed in box and 11 of them were randomly drawn to serve as intervention areas by one of the trainees in presence of the representatives of the 22 communities\' health centres\"

  Allocation concealment (selection bias)                       High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \"The study was an open cluster-randomised trial\... The health areas were numbered from 1 to 22 and each number was written on piece of paper that was folded. The 22 pieces of paper were then mixed and placed in box and 11 of them were randomly drawn to serve as intervention areas by one of the trainees in presence of the representatives of the 22 communities\' health centres\"

  Blinding (performance bias and detection bias) All outcomes   High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Study was open cluster-randomised trial. 2 cross-sectional surveys (using the WHO method of evaluation of vaccine coverage) performed, 1 at baseline and 1 after 1 year of the intervention. Did not state whether the people conducting the survey were aware of the treatment allocations or not

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Not applicable; 2 independent samples taken pre- and post-intervention

  Selective reporting (reporting bias)                          Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            No selective reporting

  Other bias                                                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            None

  Baseline outcome measurements similar?                        High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           No. Difference was statistically significant

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Yes

  Adequate protection against contamination?                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Training of staff was carried out in both control and intervention communities, followed by public randomisation
  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Djibuti 2009

  ------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Cluster RCT in Georgia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Participants                                                  Setting: low immunisation coverage despite healthcare reforms. Human resource management was weak with lack of knowledge and skills in management and supervision especially at the peripheral levels\                                                                                                                                                                                                                                                                                                                                                                        
                                                                Participants: district immunisation managers, PHC providers. Number of health workers studied was 392 at pre-intervention and 521 at post-intervention. Apart from outcome measures from PHC workers, data were obtained on children\'s immunisation                                                                                                                                                                                                                                                                                                                          

  Interventions                                                 **Intervention:***development of supportive supervision guidelines for district immunisation managers in 15 clusters: i*ntervention consisted of development of supportive supervision guidelines and tools for district managers, training in continuous supportive supervision, monitoring, and evaluation of performance. Each district manager visited subordinated health facility at least once a month. On-the-job training was provided for immunisation managers to improve on supervision practices to help providers solve problems encountered in immunisation\   
                                                                **Control:** no intervention in 15 control clusters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Outcomes                                                      DTP3, polio 3, and HBV3 coverage\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                Difference in proportion of coverage from baseline                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Duration of intervention                                      12 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Notes                                                         Follow-up study conducted after 1 year of intervention                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \"Stratified cluster randomisation was used to select the 30 cluster units out of the nation\'s 67 districts and allocate them into the two study groups (intervention and control), yielding two allocation sequences of 15 clusters each\"

  Allocation concealment (selection bias)                       Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \"Given that immunization managers supervise health workers only within their districts, and similarly health workers provide immunization services to target population residing in communities within the same district, the risk of contamination of the control group with the intervention is negligible. Use of smaller units (e.g. village) would have posed a higher risk of contamination of intervention activities in control clusters\"

  Blinding (performance bias and detection bias) All outcomes   Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Unclear

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Not applicable; 2 independent samples taken pre- and post-intervention 

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Unclear if all the outcomes stated in the protocol were reported on

  Other bias                                                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     During the course of intervention, the country improved healthcare financing for low-income people and there was also improved country level economic growth thus improving access to health care. \"It is possible that improved access to health care may have contributed to improved immunization coverage in Georgia\"\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Unit of study was district, but unit of analysis was participant. No adjustment for clustering effect

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Yes

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Demographic and employment characteristics were similar among Center of Public Health staff respondents in the intervention and control groups, both at baseline and follow-up except mean years of experience, which was more among the control group

  Adequate protection against contamination?                    Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Protection against contamination unclear 
  ------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Maluccio 2004

  ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Cluster RCT conducted in Nicaragua (Red de proteccion social)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Participants                                                  Setting: part of a social safety net programme targeted at poor households living in rural areas, but the pilot phase analysed in this study occurred in 2 departments (Madriz and Matagalpa) in the Northern part of the Central Region. This region is the only one in the country where poverty worsened during 1998 and 2001\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                These pilot sites were not representative of the country situation: within the 2 chosen departments, 6 municipalities were chosen (out of 20) because they had benefited from a previous programme that developed the capacity of the governing bodies to implement and monitor social projects: \"it is possible that the selected municipalities had atypical capacities to run RPS\" in the chosen municipalities, 78-90% of the population was extremely poor/poor, compared to 21-45% at national level. 42 eligible areas (the neediest) were chosen for the pilot programme based on wealth index\                                                                                                                                                                                                                                                
                                                                Private providers were specifically trained to deliver the specific healthcare services required by the programme. Incentives were also given to teachers to compensate for the larger classes they had after the implementation of the programme. 10% of beneficiaries were penalised at least once during the first 2 years of the programme; 5% were expelled or left the programme. Some conditions (adequate weight gain) were dropped at the end of the pilot phase and others were not properly enforced (up-to-date vaccination while there were delays in the delivery of vaccines)\                                                                                                                                                                                                                                                            
                                                                Delays occurred in the implementation of the health component, which finally started in June 2001. Therefore, when the first follow-up survey was realised in October 2001, the beneficiaries had been receiving the transfers for the education component for 13 months and those for the health and nutrition component for 5 months only\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                Participants: All households except 169 (2.9% of households that lived in the intervention area) that owned either a vehicle (truck, pickup truck, or jeep) or land =14.1 hectares or both.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Interventions                                                 **INTERVENTION:** in 21 clusters\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                Programme had 2 components:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                monthly \"food security\" cash transfer (\"bono alimentario\" = USD224 per year = 13% of total amount of household expenditures in beneficiary households before the programme) conditional on attendance at monthly health educational workshops, on bringing their children under age 5 years for free scheduled preventive childcare appointments (which included the provision of anti-parasitic medication, and vitamins and iron supplements), on having up-to-date vaccination, and on adequate weight gain.A \"school attendance\" cash transfer every 2 months (USD112 per year = 8% of total amount of household expenditures in beneficiary households), contingent on enrolment and regular school attendance of children aged 7-13 years. In addition, household received an annual cash transfer per eligible child for school supplies\   
                                                                Beneficiaries did not receive the food or education cash transfers if they failed to comply with any of the conditions\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                **CONTROL:** no intervention in the 21 control clusters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Outcomes                                                      Immunisation coverage: reported up-to-date vaccination schedule (children aged 12-23 months)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                Health services uptake: attendance of preventive care visits by children\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                Anthropometric or nutritional outcomes: prevalence of stunting, wasting, and underweight (children aged \< 5 years)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                Height for age Z-score (children aged \< 5 years)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                Prevalence of anaemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Duration of intervention                                      5 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Notes                                                         The \"Red de Proteccion Social\" project was financed by a loan from the Inter-American Development Bank. The impact analysis of the pilot phase was done by the International Food Policy Research InstitutePossible detection of the \"Hawthorne effect\" since performance of the programme was slightly lower the second yearOver the 2 years, the actual mean monetary transfer to households represented 18% of total household expenditure (similar to PROGRESA but 5 times larger than Programa de Asignación Familiar). The nominal transfers remained constant during the 2 years of the programme, thus the real value of the transfer declined by 8% due to inflation                                                                                                                                                                        

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \"Random selection by balloting within each stratum, randomisation was achieved by blindly drawing one of six coloured balls (three blue for intervention, three white for control) from a box after the name of each comarca \[region\] was called out\"

  Allocation concealment (selection bias)                       High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Randomisation not concealed

  Blinding (performance bias and detection bias) All outcomes   High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Study not blinded

  Incomplete outcome data (attrition bias) All outcomes         High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Reasons for attrition not given

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Unclear if all outcomes stated in the protocol were reported on

  Other bias                                                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \"In October 2001, then, beneficiaries had been receiving transfers, and the educational components of the program had been monitored for 13 months, but they had only received five months of the health and nutrition services, including the health education workshops\"\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \"It is important to emphasize that for most of the indicators considered, the control group also showed large improvements over the period, although on a much smaller scale. A possible explanation for this increase is that other providers are bringing health services into the areas not covered by the program (program providers do not offer or deliver any services to non-beneficiaries)\"

  Baseline outcome measurements similar?                        Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Baseline number of children aged 12-23 months with updated immunisation similar between baseline and control

  Baseline characteristics similar?                             Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Baseline characteristics on the intervention and control groups not stated. Author reported \"few significant difference between households (or individuals) in intervention and control groups at baseline\" but was unclear if the difference were related to outcomes of the review

  Adequate protection against contamination?                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \"Control and intervention comarcas \[regions\] are at times adjacent to one another. A household may be a beneficiary while its neighbour is a nonbeneficiary, particularly in a few cases where boundaries such as roads divide two comarcas. Seeing the activity and the emphasis placed on the RPS objectives may lead non-beneficiaries to undertake behavior they would not have otherwise. Reasons for such actions could be many - including the possibility that the individuals thought this was a way to become eligible\"
  ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Morris 2004

  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Cluster RCT in Honduras                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Participants                                                  Participants: households in 70 clusters including pregnant women, new mothers, and children aged \< 3 years. Outcome on immunisation was measured in 4359 children at pre-intervention and 3876 at post-intervention\                                                                                                                                                                                                                                                                                                                                               
                                                                Aim: to drive demand, poor households benefited from cash transfer on the condition that they keep up-to-date with preventive healthcare services.                                                                                                                                                                                                                                                                                                                                                                                                                  

  Interventions                                                 **Intervention A:***household monetary incentive in 20 clusters:* consisted of distribution of vouchers worth GBP2.53 to mothers who were registered in 2000 census who were either pregnant or had a child \< 3 years of age to a maximum of 2 children. In addition, mothers with children aged 6-12 years enrolled in primary schools in grade 1-4 given vouchers worth GBP3.69 per month. Beneficiaries lost aid if they were not up-to-date with routine antenatal care, and well-child preventive health care and if child did not attend school regularly\   
                                                                **Intervention B:***service-level monetary incentive in 10 clusters:* quality assurance teams set up at each health centre and trained on basic quality assurance methods. They developed work plans that included minor structural repairs; purchase of equipment, materials, and essential drugs; and money to pay lay assistants. Package included promotion of community-based nutrition programme for children aged \< 2 years\                                                                                                                                
                                                                **Intervention C:** combination of household and service-level monetary incentives (i.e. Interventions A + B) in 20 clusters\                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                **Control:** standard (routine) care in 20 clusters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Outcomes                                                      Proportion of pregnant women immunised against tetanus\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                Proportion of children aged 93 days to 3 years who received first dose of DTP or pentavalent vaccine (diphtheria, tetanus, pertussis, Haemophilus influenzae type B, hepatitis B) at 42-92 days of age\                                                                                                                                                                                                                                                                                                                                                             
                                                                Proportion of children aged 1 year old immunised against measles                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Duration of intervention                                      1 year                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Notes                                                         2 years of follow up.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Children made to pick coloured balls from a box where aperture would not allow the children to see the ballot balls

  Allocation concealment (selection bias)                       High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \"From the day of the randomisation onwards, there was no attempt to conceal the allocation, but it was not possible for a household to become eligible for the vouchers by moving into a beneficiary municipality. On the other hand, it was not possible to restrict usage of \'improved\' health services to residents of the appropriate municipality\"

  Blinding (performance bias and detection bias) All outcomes   Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Unclear

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \"Loss to follow up did not exceed 5%\"

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Unclear what outcomes were stated in the protocol

  Other bias                                                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Service package could not be provided according to the protocol and training on quality assurance was limited to only the introduction. Disbursement of funds for this was only 17% of the budget\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Unit of randomisation was municipalities. Analysis not adjusted for cluster effect

  Baseline outcome measurements similar?                        High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           The coverage of DTP1 vaccine in the group receiving intervention C (intervention A + B) was lower than the other 3 groups

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Demographic and socioeconomic data of the 4 groups similar

  Adequate protection against contamination?                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           It was possible for participants from other arms of study to attend services at improved centres. 14% of children aged \< 3 years attended clinics in municipalities other than their municipality of residence 1 month prior to post-intervention survey
  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Owais 2011

  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       RCT in Pakistan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Participants                                                  Setting: urban and semi-urban communities with low literacy and low immunisation coverage\                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                Participants: 364 mother-infant pairs, with infants aged ≤ 6 weeks. Excluded twin births, infants = 6 weeks of age, or infants born to mothers living outside the study surveillance areas. Cut-off of 6 weeks used to ensure that the intervention was implemented before the first dose of DTP/hepatitis B became due                                                                                                                                                                                                                        

  Interventions                                                 **Intervention:** 3 targeted pictorial messages regarding vaccines administered by trained CHWs. First key message highlighted how vaccines save children\'s lives. Second message provided logistic information about the address and location of the local vaccination centres. Third key message emphasised the significance of retaining immunisation cards, and role they could play at the time of the child\'s school admissions. Copy of these pictorial messages was left with the mother. Messages took about 5 minutes to impart\   
                                                                **Control:** verbal general health promotion messages delivered by trained CHWs. Messages included information on hand washing, breastfeeding, clean water, benefits of using oral rehydration solutions during diarrhoea, bringing the infant to nearby health centre when there were symptoms of acute respiratory illnesses, importance of antenatal check-ups for mothers, and some general information on vaccines. Length of each educational session was approximately 10-15 minutes                                                    

  Outcomes                                                      DTP/hepatitis B vaccine completion (3 doses) at 4 months after enrolment (4-5 months of infant\'s age)                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Duration of intervention                                      4 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Notes                                                         Community-based study conducted at 5 low-income sites in Karachi, Pakistan. Participants were enrolled from August 2008 to November 2008 and followed up for assessment of outcome from December 2008 to March 2009, with each individual mother-infant pair approached 4 months after the educational intervention session                                                                                                                                                                                                                    

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \"Randomization lists, stratified for each of the five enrolment sites were generated by a computer and provided to the CHWs. Upon consent, mother-infant pairs were assigned either to intervention or control arms through block randomisation (n = 4), according to the computer-generated list\"

  Allocation concealment (selection bias)                       Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Not described

  Blinding (performance bias and detection bias) All outcomes   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \"As the intervention was educational, blinding of study staff and participants was not possible\... Outcome assessment was done by an investigator \... blinded to the exposure status of participants\"

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Outcome data not available for 2% (4/183) in the intervention group (0 deaths) and 3% (5/183) in the control group (3 deaths)

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Unclear what outcomes were stated in the protocol

  Other bias                                                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       None

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Yes

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Yes

  Adequate protection against contamination?                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Yes
  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Pandey 2007

  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Cluster RCT in India                                                                                                                                                                                                                                                                                                                                                   

  Participants                                                  Setting: community-based trial\                                                                                                                                                                                                                                                                                                                                        
                                                                Aim: tested the hypothesis that informing the community will enhance accountability of the health workers towards quantity and quality of services rendered. Resource poor rural populations were informed about entitled services\                                                                                                                                    
                                                                Participants: households with at least 1 child going to public primary school in the village. Immunisation coverage targeted children aged 0-35 months. 1025 children included                                                                                                                                                                                         

  Interventions                                                 **Intervention:***information campaign in 11 clusters;* 2 rounds of information campaigns consisting of 2 or 3 meetings and distribution of posters and leaflets. 15-minute audiotaped message played twice at each meeting and 15 minutes given for questions. To ensure uniformity only questions for which answers were written in the leaflet were responded to\   
                                                                **Control:** no intervention in 10 control clusters                                                                                                                                                                                                                                                                                                                    

  Outcomes                                                      Received tetanus vaccination\                                                                                                                                                                                                                                                                                                                                          
                                                                Received at least 1 vaccine                                                                                                                                                                                                                                                                                                                                            

  Duration of intervention                                      Each of the 2 rounds of meetings lasted for 1 hour and each round was separated by 2 weeks                                                                                                                                                                                                                                                                             

  Notes                                                         Post-intervention data collected 12 months after                                                                                                                                                                                                                                                                                                                       

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                       

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                    Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                               Randomly generated numbers

  Allocation concealment (selection bias)                       Unclear risk                                                                                                                                                                                                                                                                                                                                                           Unclear

  Blinding (performance bias and detection bias) All outcomes   Low risk                                                                                                                                                                                                                                                                                                                                                               Research assistants at post-intervention had no knowledge of the intervention

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                               2.4% loss to follow-up

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                           Unclear what outcomes were stated in the protocol

  Other bias                                                    High risk                                                                                                                                                                                                                                                                                                                                                              Proportion at campaign meetings 11-14% and long recall period\
                                                                                                                                                                                                                                                                                                                                                                                                                                       Unit of study was village; unit of analysis was household. No adjustment for clustering effect

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                               Difference between proportion of children immunised at baseline in the 2 groups was not statistically significant

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                               Yes

  Adequate protection against contamination?                    Unclear risk                                                                                                                                                                                                                                                                                                                                                           \"By randomly selecting only 5 village clusters of about 1000 in each district, we spread the selection of 105 village clusters over 21 districts to minimize any potential for contamination\"
  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Robertson 2013

  ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       Matched, cluster RCT in 10 sites in Manicaland, Zimbabwe                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Participants                                                  Aim: tested effect of conditional and unconditional cash transfer among poor and vulnerable populations in Zimbabwe\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                Setting and participants: \"We ranked households according to their index score and then divided them into quintiles in each study site, thus identifying the poorest 20% of households in each site\... Eligible households contained children younger than 18 years and satisfied at least one other criteria: head of household was younger than 18 years; household cared for at least one orphan younger than 18 years, a disabled person, or an individual who was chronically ill; or household was in poorest wealth quintile.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                Households within the clusters were eligible for inclusion in the trial when they contained children younger than 18 years and satisfied at least one other criteria at baseline: the head of the household was younger than 18 years; the household cared for at least one orphan (a child younger than 18 years with one or more deceased parents), disabled person, or an individual who was chronically ill; or the household was in the poorest wealth quintile. Households in the richest wealth quintile and those already receiving cash transfers for orphans and vulnerable children were not eligible.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                We did a baseline survey of all households in the trial clusters between July, and September, 2009. We counted how many members made up each household and obtained information about trial endpoints and eligibility and exclusion criteria, including house hold asset data. We constructed a wealth index with a simple sum of reported household assets (appendix). We ranked households according to their index score and then divided them into quintiles in each study site, thus identifying the poorest 20% of households in each site. We obtained informed consent from the most senior member of the household available at time of interview\"                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Interventions                                                 **Intervention:** unconditional cash transfers in 1525 households, conditional cash transfers in 1319 households\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                \"Every household enrolled in the UCT \[unconditional cash transfer\] programme collected US\$ \[USD\] 18 plus \$4 per child in the household (up to a maximum of three children) from designated pay points every 2 months.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                Households in the CCT \[conditional cash transfer\] group could receive the same amount, but were monitored for compliance with several conditions: an application for a birth certificate had to be made within 3 months for all children younger than 18 years (including newborn babies) whose births had not been registered; children younger than 5 years had to be up-to-date with vaccinations and attend growth monitoring clinics twice a year; children aged 6--17 years had to attend school at least 90% of the time per month; and a representative from every household had to attend two-thirds of local parenting skills classes. Compliance cards were issued to CCT households and were signed by service providers when beneficiaries accessed services. The signed cards were brought to the pay points every 2 months, along with other documents such as birth certificates, child health cards, and receipts for the payment of school fees. Community committees were familiar with most people living in the trial clusters. If a household provided a good reason for not meeting conditions (e.g. a child missing school because of illness), it was verified by the committee and judged on a case-by-case basis\"\   
                                                                **Control:** no intervention in 1199 households                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Outcomes                                                      3 domains of child well-being (identity, health, and education)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                Proportion of children aged \< 5 years with a birth certificate\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                Proportion of children aged \< 5 years with up-to-date vaccinations (measles, BCG, polio, and DTP)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                Proportion of children aged 6-12 years attending school at least 80% of the time in the previous month                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Duration of intervention                                      13 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Notes                                                         \"After the baseline survey, clusters were randomly assigned to UCT \[unconditional cash transfer\], CCT \[conditional cash transfer\], or control at public meetings that any community members could attend. In each site, one cluster was assigned to UCT, one to CCT, and one to control. Allocation was done by the drawing of lots from a hat. Participating households and individuals delivering the intervention were not masked to cluster assignment.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                At follow-up, research assistants were not told the allocation of the household they were interviewing, but questions were included at the end of the questionnaire about whether households received transfers. LR was masked when doing the primary analysis\"                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Randomisation through balloting

  Allocation concealment (selection bias)                       High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Randomisation not concealed

  Blinding (performance bias and detection bias) All outcomes   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Study was single blinded. \"LR was masked while doing the primary analysis\"

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Lost to follow-up accounted for and analysis was by intension to treat

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Study protocol not available

  Other bias                                                    Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       2 villages randomised into the control group were mistakenly enrolled in the unconditional cash transfer group. Duration of study was shortened from 24 to 13 months due to lack of funds

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Yes

  Baseline characteristics similar?                             High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Some characteristics were dissimilar

  Adequate protection against contamination?                    High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Almost one-third of those for UCT reported having to comply with conditions
  ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Usman 2009

  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       RCT in Pakistan                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Participants                                                  Setting: reminder intervention in an urban setting in Pakistan to reduce drop-out rate in DTP3\                                                                                                                                                                                                                                                                                                                                                                  
                                                                Participants: 375 mothers visiting the EPI centre in each of 4 arms of study with 1125 children registering for DTP1 immunisation and residing in the study area for the past 6 months                                                                                                                                                                                                                                                                           

  Interventions                                                 **Intervention A:***redesigned (\"reminder-type\") immunisation card*; a larger card (15.5 cm by 11.5 cm when folded) that had only the date and day of next immunisation on both sides of the outer card printed with Microsoft Word font size 42 was designed as a reminder for mothers/carers for immunisation. Inner side of the card contained information about the child\'s complete immunization schedule dates and instructions for the mother/carer\   
                                                                For those in the arm for redesigned card, the date and day for each DTP vaccination was written on the outer side of the card; dates of previous vaccinations were crossed out to avoid confusion. Mother was advised to place the card at a frequently visible place at home and to bring it to the clinic during immunisation visits\                                                                                                                          
                                                                **Intervention B:***centre-base education*; clinic-based education that lasted 2-3 minutes given to mothers at enrolment of their children in the EPI centre. The health education emphasised the importance of immunisation schedule completion\                                                                                                                                                                                                                
                                                                **Intervention C:** intervention 1 + 2\                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                **Control:** standard care                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Outcomes                                                      Number of enrolled children with DTP3 completed within 90 days of duration of study                                                                                                                                                                                                                                                                                                                                                                              

  Duration of intervention                                      2-3 minutes per session; follow-up for 90 days                                                                                                                                                                                                                                                                                                                                                                                                                   

  Notes                                                         Urban Pakistan                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                              Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                         Allocation sequence was by computer-generated randomisation list

  Allocation concealment (selection bias)                       Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                     Unclear whether allocation was concealed

  Blinding (performance bias and detection bias) All outcomes   High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                        Neither the participant nor the assessor was blinded

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                         No loss to follow-up

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                     Unclear what outcomes were stated in the protocol

  Other bias                                                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                         No other bias detected

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                         Not applicable

  Baseline characteristics similar?                             High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                        Most of the socioeconomic variables were similar but ownership of a television was more among group receiving education and a higher proportion of those receiving standard care lived close to the facility than those in the redesigned card group

  Adequate protection against contamination?                    Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                     Unclear
  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Usman 2011

  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                       RCT in Pakistan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Participants                                                  Setting: rural setting in Pakistan\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                Aim: to test theory that reminder intervention can reduce drop-out rate for DTP3 vaccination\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                Participants: 1508 mother-child pair visiting selected EPI centres for DTP1 who were resident in study area for at least 6 months. Criterion used to exclude 2 groups of temporary residents: women who temporarily relocated to their mothers\' houses to deliver their children and internally displaced families who had migrated to the study area to avoid the aftermath of 2005 earthquake in the north of Pakistan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Interventions                                                 **Intervention A:***redesigned (\"reminder-type\") immunisation card*; a larger card than the existing EPI card (15.5 cm by 11.5 cm when folded), placed in a plastic jacket and provided with a hanging string. A \"trained interviewer pasted the upcoming date and day of DTP2 immunization on both outer sides of the card and showed it to the mother. Mother was asked to hang the card in her home at a frequently visible place and requested that she bring the card along on her next immunization visit to the EPI centre. At DTP2 visit, the interviewer crossed out the date and day for DTP2 visit to avoid any confusion to the mothers, pasted the date and day for the upcoming DTP3 immunization visit on both sides of the card and showed the information to the mother.\" The inner side of the card contained information about the child\'s complete immunisation schedule dates and instructions for the mother\   
                                                                **Intervention B:***centre-base education*; 2- to 3-minute conversation between trained study interviewer and mother to convey the importance of completing the immunisation schedule and the potential adverse impact of incomplete immunisation on the child\'s health. Session was in simple vocabulary in the local language and deliberately kept short in prevision of potential large-scale use by EPI staff in the future\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                **Intervention C:** combination of redesigned card and centre-based education\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                **Control:** standard care i.e. routine EPI centre visit and neither intervention                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Outcomes                                                      DTP3 coverage at the end of day 90 post-enrolment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Duration of intervention                                      2-3 minutes per session; follow-up at 90 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Notes                                                         Rural areas around Karachi, Pakistan. Despite a small purchase volume, the cost of each card including the plastic jacket was USD0.05                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Bias                                                          Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Support for judgement

  Random sequence generation (selection bias)                   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \"The lead investigator provided a computer-generated randomisation list to each enrolment centre\"

  Allocation concealment (selection bias)                       Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \"Each enrolled mother-child pair received an identification number (ID) from the randomisation list and was assigned to the study group corresponding to the ID on the list\"

  Blinding (performance bias and detection bias) All outcomes   High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \"Because of the overt nature of interventions, neither the study participants nor the interviewers enrolling the study participants and recording the study outcome were blinded to the type of intervention received by the study participants\"

  Incomplete outcome data (attrition bias) All outcomes         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   No loss to follow-up

  Selective reporting (reporting bias)                          Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Unclear what outcomes were stated in the protocol

  Other bias                                                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   No other bias detected

  Baseline outcome measurements similar?                        Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Not applicable

  Baseline characteristics similar?                             Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Yes

  Adequate protection against contamination?                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \"Interventions were provided in a private space to prevent contamination between study groups\"
  ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BCG: Bacille Calmette-Guérin; CHW: community health worker; DTP: diphtheria-tetanus-pertussis; EPI: Expanded Programme on Immunization; HBV3: three doses of hepatitis B virus; OPV: oral polio vaccine; PHC: primary healthcare; RCT: randomised controlled trial; WHO: World Health Organization.

Characteristics of excluded studies \[ordered by study ID\] {#sec02}
-----------------------------------------------------------

  --------------------- ----------------------------------------------------------------------------------------
  Study                 Reason for exclusion
  Abdul Rahman 2013     A controlled before-and-after study with single unit for intervention and control arms
  al Teheawy 1992       Retrospective study
  Alto 1989             Observational study
  Aneni 2013            Observational study
  Anjum 2004            A controlled before-and-after study with single unit for intervention and control arms
  Attanasio 2005        No relevant data on outcome
  Balraj 1986           Programme evaluation
  Bandyopadhyay 1996    Observational study
  Barham 2009           Programme evaluation
  Bazos 2015            No relevant data on outcome
  Berhane 1993          No relevant outcome. Reports on drop-out rate
  Berman 1991           Observational study
  Berry 1991            Observational study
  Bishai 2002           No relevant data on outcome
  Chandir 2010          Observational study
  Chen 1976             Retrospective study
  Chen 1989             Observational study
  Cutts 1990            Observational study
  Cutts 1994            Observational study
  Dammann 1990          Observational study
  Dini 1995             No relevant data on outcome
  Dominguez Ugá 1988    Observational study
  Ekunwe 1984           Observational study
  Gomber 1996           Observational study
  Hayford 2014          Observational study
  Hong 2005             Observational study
  Hu 2015               A controlled before-and-after study with single unit for intervention and control arms
  Igarashi 2010         A controlled before-and-after study with single unit for intervention and control arms
  Kaewkungwal 2015      Observational study
  Kuhn 1990             Observational study
  Kumar 1990            Observational study
  Lechtig 1981          A controlled before-and-after study with single unit for intervention and control arms
  Lin 1971              Observational study
  Linkins 1995          Observational study
  Maher 1993            Observational study
  Main 2001             Observational study
  Marshall 2007         Retrospective study
  Ndiritu 2006          Observational study
  Osinka 2000           Observational study
  Pan 1999              Observational study
  Pierce 1996           A controlled before-and-after study with single unit for intervention and control arms
  Prinja 2010           A controlled before-and-after study with single unit for intervention and control arms
  Przewlocka 2000       Observational study
  Robinson 2001         Observational study
  Ryman 2011            Data not summarised by the study groups
  San Sebastian 2001    Observational study
  Shaikh 2003           Observational study
  Sutanto 1999          Observational study
  Uddin 2010            A controlled before-and-after study with single unit for intervention and control arms
  Uddin 2012            Study had no control arm
  Uskun 2008            Observational study
  van Zwanenberg 1988   Observational study
  Wang 2007             No relevant outcome for the review
  Zimicki 1994          Observational study
  --------------------- ----------------------------------------------------------------------------------------

Characteristics of studies awaiting assessment \[ordered by study ID\] {#sec04}
----------------------------------------------------------------------

###### 

Ali 2015

  --------------- --------------------------------------------------------------------------------------------------------------------
  Methods         A quasi-experimental study in rural Pakistan

  Participants    Household heads

  Interventions   Community service in intervention clusters (government Basic Health unit) versus standard care in control clusters

  Outcomes        Knowledge and practices regarding routine immunisation,\
                  Fully vaccinated children, partially vaccinated children, un-vaccinated children.

  Notes           
  --------------- --------------------------------------------------------------------------------------------------------------------

###### 

Bangure 2015

  --------------- ------------------------------------------------------
  Methods         Randomised controlled trial in Kadoma City, Zimbabwe
  Participants    Women at delivery
  Interventions   SMS reminders versus standard care
  Outcomes        Immunisation coverage, timely vaccinations
  Notes           
  --------------- ------------------------------------------------------

###### 

Basinga 2011

  --------------- -----------------------------------------------------------------------------------------------------------------------------
  Methods         Cluster RCT in Rwanda
  Participants    Healthcare providers
  Interventions   Performance-based payment of healthcare providers (payment for performance; P4P) versus traditional input-based funding
  Outcomes        Immunisation, prenatal care visits and institutional deliveries, quality of prenatal care, and child preventive care visits
  Notes           
  --------------- -----------------------------------------------------------------------------------------------------------------------------

###### 

Briere 2012

  --------------- ------------------------------------------------------------------------
  Methods         controlled before-after study in rural Kenya
  Participants    Caregivers of children aged 2-13 months
  Interventions   Free hygiene kits and education about water treatment and hand hygiene
  Outcomes        Fully vaccinated children
  Notes           
  --------------- ------------------------------------------------------------------------

###### 

Brown 2016

  --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods         Cluster RCT in Ibadan, Nigeria
  Participants    Children aged 0-12 weeks
  Interventions   Mobile phone reminders and recall *versus* Primary Health Care immunisation providers\' training *versus* combined Mobile phone reminders and recall *versus* Primary Health Care immunisation providers\' training *versus* standard care
  Outcomes        Children fully vaccinated at 12 months of age
  Notes           
  --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Busso 2015

  --------------- ------------------------------------------------
  Methods         A field experiment in rural Guatemala
  Participants    Families whose children were due for a vaccine
  Interventions   Personal reminders versus standard care
  Outcomes        Fully vaccinated children
  Notes           
  --------------- ------------------------------------------------

###### 

Domek 2016

  --------------- ------------------------------------------------------------------------------------------------
  Methods         RCT in Guatemala City
  Participants    Caregivers of infants aged 8-14 weeks presenting for first dose of primary immunisation series
  Interventions   Mobile phone short message service versus standard care
  Outcomes        Fully vaccinated infants
  Notes           
  --------------- ------------------------------------------------------------------------------------------------

###### 

Gokcay 1993

  --------------- ----------------------------------------------------------------------------------------------
  Methods         Random allocation of paraprofessionals and Midwives to \"visiting area\" in Istanbul, Turkey
  Participants    Midwives and lady home visitors (paraprofessionals) and children aged \< 5 years
  Interventions   Use of lay home visitors vs. midwives for home visit
  Outcomes        Infants fully vaccinated, children aged \< 5 fully vaccinated.
  Notes           
  --------------- ----------------------------------------------------------------------------------------------

###### 

Haji 2016

  --------------- ----------------------------------------------------------------------------------------------------
  Methods         Random allocation of three facilities in three districts in Kenya to two interventions and control
  Participants    children less than 12 months
  Interventions   Reminder text message vs reminder sticker
  Outcomes        Receipt of DTP 2 and DTP 3 at 10 and 14 weeks; dropout rate
  Notes           
  --------------- ----------------------------------------------------------------------------------------------------

###### 

Johri 2015a

  --------------- ------------------------------------------------------------------------------------------------------------------------------------
  Methods         Cluster RCT in rural Uttar Pradesh, India
  Participants    Mothers of children 0-23 months of age were eligible
  Interventions   Home visits by volunteers plus community mobilisation to promote immunisation *versus* community mobilisation to promote nutrition
  Outcomes        Primary outcomes were feasibility of recruitment, randomisation and retention of participants
  Notes           
  --------------- ------------------------------------------------------------------------------------------------------------------------------------

###### 

Linkins 1994

  --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods         Randomised controlled trial
  Participants    Children aged \< 2 years, had telephone numbers listed in pre-exiting computerised database, and were due or late for immunisation(s) during the 4-month enrolment period
  Interventions   Household of children were randomised to receive or not receive a general or vaccine-specific computer generated telephone reminder message 1 day before the child was due, or immediately after randomisation if the child was late
  Outcomes        The rate of immunisation visits in the 30-day follow-up period
  Notes           
  --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Uddin 2016

  --------------- -----------------------------------------------------------
  Methods         Non randomised trial in urban and rural Bangladesh
  Participants    Families of children in need of vaccination
  Interventions   Mobile phone short message service *versus* standard care
  Outcomes        Fully vaccinated children
  Notes           
  --------------- -----------------------------------------------------------

Data and analyses
=================

###### 

Health education

  ----------------------------------------------------------- ---------------- --------------------- ----------------------------- ---------------------
  Outcome or subgroup title                                   No. of studies   No. of participants   Statistical method            Effect size
  [1 Measles vaccine](#fig101){ref-type="fig"}                1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  [2 DTP3](#fig102){ref-type="fig"}                           5                                      Risk Ratio (Random, 95% CI)   Subtotals only
   [2.1 Community-based education](#fig102){ref-type="fig"}   2                                      Risk Ratio (Random, 95% CI)   1.68 \[1.09, 2.59\]
   [2.2 Facility-based education](#fig102){ref-type="fig"}    3                                      Risk Ratio (Random, 95% CI)   1.20 \[0.97, 1.48\]
  [3 Received at least 1 vaccine](#fig103){ref-type="fig"}    1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  ----------------------------------------------------------- ---------------- --------------------- ----------------------------- ---------------------

###### 

Health education plus redesigned reminder card

  ----------------------------------- ---------------- --------------------- ----------------------------- ---------------------
  Outcome or subgroup title           No. of studies   No. of participants   Statistical method            Effect size
  [1 DTP3](#fig201){ref-type="fig"}   2                                      Risk Ratio (Random, 95% CI)   1.50 \[1.21, 1.87\]
  ----------------------------------- ---------------- --------------------- ----------------------------- ---------------------

###### 

Household monetary incentive

  ------------------------------------------------------------------------------ ---------------- --------------------- ----------------------------- ---------------------
  Outcome or subgroup title                                                      No. of studies   No. of participants   Statistical method            Effect size
  [1 Measles](#fig301){ref-type="fig"}                                           1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  [2 Fully immunised children](#fig302){ref-type="fig"}                          2                                      Risk Ratio (Random, 95% CI)   1.05 \[0.90, 1.23\]
  [3 BCG](#fig303){ref-type="fig"}                                               1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  [4 MMR](#fig304){ref-type="fig"}                                               1                                      Risk Ratio (Random, 95% CI)   Totals not selected
   [4.1 Household monetary incentive](#fig304){ref-type="fig"}                   1                                      Risk Ratio (Random, 95% CI)   0.0 \[0.0, 0.0\]
   [4.2 Service-level monetary incentive](#fig304){ref-type="fig"}               1                                      Risk Ratio (Random, 95% CI)   0.0 \[0.0, 0.0\]
   [4.3 Household + service-level monetary incentive](#fig304){ref-type="fig"}   1                                      Risk Ratio (Random, 95% CI)   0.0 \[0.0, 0.0\]
  [5 DTP1](#fig305){ref-type="fig"}                                              1                                      Risk Ratio (Random, 95% CI)   Totals not selected
   [5.1 Household monetary incentive](#fig305){ref-type="fig"}                   1                                      Risk Ratio (Random, 95% CI)   0.0 \[0.0, 0.0\]
   [5.2 Service-level monetary incentive](#fig305){ref-type="fig"}               1                                      Risk Ratio (Random, 95% CI)   0.0 \[0.0, 0.0\]
   [5.3 Household + service-level monetary incentive](#fig305){ref-type="fig"}   1                                      Risk Ratio (Random, 95% CI)   0.0 \[0.0, 0.0\]
  ------------------------------------------------------------------------------ ---------------- --------------------- ----------------------------- ---------------------

###### 

Home visit

  -------------------------------------- ---------------- --------------------- ----------------------------- ---------------------
  Outcome or subgroup title              No. of studies   No. of participants   Statistical method            Effect size
  [1 OPV3](#fig401){ref-type="fig"}      1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  [2 Measles](#fig402){ref-type="fig"}   1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  -------------------------------------- ---------------- --------------------- ----------------------------- ---------------------

###### 

Regular immunisation outreach

  --------------------------------------------------------------------------- ---------------- --------------------- ---------------------------- ---------------------
  Outcome or subgroup title                                                   No. of studies   No. of participants   Statistical method           Effect size
  [1 Fully immunised children](#fig501){ref-type="fig"}                       1                                      Risk Ratio (Fixed, 95% CI)   Totals not selected
   [1.1 Regular immunisation outreach only](#fig501){ref-type="fig"}          1                                      Risk Ratio (Fixed, 95% CI)   0.0 \[0.0, 0.0\]
   [1.2 Regular immunisation outreach + incentive](#fig501){ref-type="fig"}   1                                      Risk Ratio (Fixed, 95% CI)   0.0 \[0.0, 0.0\]
  --------------------------------------------------------------------------- ---------------- --------------------- ---------------------------- ---------------------

###### 

Integration of immunisation to other health services

  -------------------------------------- ---------------- --------------------- ----------------------------- ---------------------
  Outcome or subgroup title              No. of studies   No. of participants   Statistical method            Effect size
  [1 BCG](#fig601){ref-type="fig"}       1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  [2 DTP3](#fig602){ref-type="fig"}      1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  [3 Measles](#fig603){ref-type="fig"}   1                                      Risk Ratio (Random, 95% CI)   Totals not selected
  -------------------------------------- ---------------- --------------------- ----------------------------- ---------------------

![Comparison 1 Health education, Outcome 1 Measles vaccine.](CD008145-0001-f1-01){#fig101}

![Comparison 1 Health education, Outcome 2 DTP3.](CD008145-0001-f1-02){#fig102}

![Comparison 1 Health education, Outcome 3 Received at least 1 vaccine.](CD008145-0001-f1-03){#fig103}

![Comparison 1 Health education plus redesigned reminder card, Outcome 1 DTP3.](CD008145-0001-f2-01){#fig201}

![Comparison 1 Household monetary incentive, Outcome 1 Measles.](CD008145-0001-f3-01){#fig301}

![Comparison 1 Household monetary incentive, Outcome 2 Fully immunised children.](CD008145-0001-f3-02){#fig302}

![Comparison 1 Household monetary incentive, Outcome 3 BCG.](CD008145-0001-f3-03){#fig303}

![Comparison 1 Household monetary incentive, Outcome 4 MMR.](CD008145-0001-f3-04){#fig304}

![Comparison 1 Household monetary incentive, Outcome 5 DTP1.](CD008145-0001-f3-05){#fig305}

![Comparison 1 Home visit, Outcome 1 OPV3.](CD008145-0001-f4-01){#fig401}

![Comparison 1 Home visit, Outcome 2 Measles.](CD008145-0001-f4-02){#fig402}

![Comparison 1 Regular immunisation outreach, Outcome 1 Fully immunised children.](CD008145-0001-f5-01){#fig501}

![Comparison 1 Integration of immunisation to other health services, Outcome 1 BCG.](CD008145-0001-f6-01){#fig601}

![Comparison 1 Integration of immunisation to other health services, Outcome 2 DTP3.](CD008145-0001-f6-02){#fig602}

![Comparison 1 Integration of immunisation to other health services, Outcome 3 Measles.](CD008145-0001-f6-03){#fig603}

Additional Tables
=================

###### 

Interventions to improve vaccination uptake and how they work

  -------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Target**                                                                                                                                               **Interventions**                                                                                                                                                                                                 **Purpose of the interventions**

  Recipients                                                                                                                                               Communication interventions to inform and educate targeting individuals, groups, communities or providers, or a combination of these through face-to-face interaction, use of mass media, printed material, etc   To improve understanding on vaccination; its relevance; benefits and risks of vaccination; where, when, and how to receive vaccine services; and who should receive vaccine services (Willis [@b139])

  Communication interventions to recall or remind using face-to-face interaction, telephone, mail, etc                                                     To remind those who are overdue for vaccination in order to reduce drop-out rate (Willis [@b139])                                                                                                                 

  Communication interventions to teach skills, e.g. parenting skills                                                                                       To provide people with the ability to operationalise knowledge through the adoption of practical skills (Willis [@b139])                                                                                          

  Communication interventions to provide support                                                                                                           To provide assistance or advice for consumers (Willis [@b139])                                                                                                                                                    

  Interventions to facilitate decision-making, e.g. decision aids on vaccination for parents                                                               To assist carers in participating in decision making ([@b91])                                                                                                                                                     

  Interventions to enable communication through traditional media, internet, etc                                                                           To make communication possible ([@b91])                                                                                                                                                                           

  Interventions, including communication, to enhance community ownership, e.g. community dialogues involving traditional and religious rulers              To increase demand for vaccination\                                                                                                                                                                               
                                                                                                                                                           To ensure sustainability\                                                                                                                                                                                         
                                                                                                                                                           To build trust in vaccination and vaccination services\                                                                                                                                                           
                                                                                                                                                           To drive demand for vaccination                                                                                                                                                                                   

  Incentives                                                                                                                                               To reward service uptake; to cover out-of-pocket cost                                                                                                                                                             

  Providers                                                                                                                                                Training                                                                                                                                                                                                          To improve knowledge on vaccination, to improve skills, to improve attitudes to clients, to reduce missed opportunities for vaccination

  Audit and feedback                                                                                                                                       To ensure quality and client satisfaction with services                                                                                                                                                           

  Supportive supervision                                                                                                                                   To ensure quality and maintain standards, to reduce missed opportunities for vaccination                                                                                                                          

  Incentives                                                                                                                                               To boost morale and enhance performance                                                                                                                                                                           

  Health system                                                                                                                                            Infrastructural development, e.g. provision of health facilities, provision of road to improve access to health facilities                                                                                        To ensure access to services

  Logistic support                                                                                                                                         To improve service quality service and so improve utilisation to ensure availability of services                                                                                                                  

  Service delivery, e.g. outreach; home visits; integration of vaccination with other services; guidelines/protocol for vaccination; increased resources   Outreach to improve access to services\                                                                                                                                                                           
                                                                                                                                                           Home visits to remind parents about vaccination and identify unimmunised children for immunisation\                                                                                                               
                                                                                                                                                           Integration to encourage vaccine uptake\                                                                                                                                                                          
                                                                                                                                                           Guidelines and protocols to ensure quality of services\                                                                                                                                                           
                                                                                                                                                           Improved resources to ensure availability of services                                                                                                                                                             

  Policy makers                                                                                                                                            Advocacy for:\                                                                                                                                                                                                    To promote the development of policies to support vaccine uptake\
                                                                                                                                                           development of supporting policies,\                                                                                                                                                                              To increase funding to the health sector
                                                                                                                                                           increased funding of health services                                                                                                                                                                              
  -------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CENTRAL, Cochrane Library

  ------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------
  ID     Search                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Hits
  \#1    MeSH descriptor: \[Immunization\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                636
  \#2    MeSH descriptor: \[Immunization Schedule\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       931
  \#3    MeSH descriptor: \[Immunization, Secondary\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     756
  \#4    MeSH descriptor: \[Immunotherapy, Active\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       109
  \#5    MeSH descriptor: \[Mass Vaccination\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            76
  \#6    MeSH descriptor: \[Immunization Programs\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       377
  \#7    MeSH descriptor: \[Vaccination\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 2330
  \#8    \#1 or \#2 or \#3 or \#4 or \#5 or \#6 or \#7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   4366
  \#9    MeSH descriptor: \[Child\] explode all trees                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    173
  \#10   MeSH descriptor: \[Infant\] explode all trees                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   14329
  \#11   MeSH descriptor: \[Mothers\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1195
  \#12   MeSH descriptor: \[Women\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       253
  \#13   MeSH descriptor: \[Pregnant Women\] this term only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              122
  \#14   \#9 or \#10 or \#11 or \#12 or \#13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             15639
  \#15   \#8 and \#14                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    369
  \#16   (immunization or immunisation or vaccination) next (program\* or rate\* or coverage or adher\*):ti                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              309
  \#17   (vaccinat\* or revaccinat\* or immunization or immunisation) near/3 (child\* or infant\* or newborn\* or neonat\* or baby or babies or kid or kids or toddler\* or woman or women or mother or mothers):ti,ab,kw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                2183
  \#18   \#15 or \#16 or \#17                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            2485
  \#19   (Africa or Asia or Caribbean or \"West Indies\" or \"South America\" or \"Latin America\" or \"Central America\"):ti,ab,kw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      6277
  \#20   (Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or Brasil or Bulgaria or \"Burkina Faso\" or \"Burkina Fasso\" or \"Upper Volta\" or Burundi or Urundi or Cambodia or \"Khmer Republic\" or Kampuchea or Cameroon or Cameroons or Cameron or Camerons or \"Cape Verde\" or \"Central African Republic\" or Chad or Chile or China or Colombia or Comoros or \"Comoro Islands\" or Comores or Mayotte or Congo or Zaire or \"Costa Rica\" or \"Cote d\'Ivoire\" or \"Ivory Coast\" or Croatia or Cuba or Cyprus or Czechoslovakia or \"Czech Republic\" or Slovakia or \"Slovak Republic\"):ti,ab,kw                                                                                                                                13336
  \#21   (Djibouti or \"French Somaliland\" or Dominica or \"Dominican Republic\" or \"East Timor\" or \"East Timur\" or \"Timor Leste\" or Ecuador or Egypt or \"United Arab Republic\" or \"El Salvador\" or Eritrea or Estonia or Ethiopia or Fiji or Gabon or \"Gabonese Republic\" or Gambia or Gaza or Georgia or Georgian or Ghana or \"Gold Coast\" or Greece or Grenada or Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary or India or Maldives or Indonesia or Iran or Iraq or \"Isle of Man\" or Jamaica or Jordan or Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or Kirghizia or \"Kyrgyz Republic\" or Kirghiz or Kirgizstan or \"Lao PDR\" or Laos or Latvia or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania):ti,ab,kw                                                                                                                                                                                                                 14788
  \#22   (Macedonia or Madagascar or \"Malagasy Republic\" or Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi or Nyasaland or Mali or Malta or \"Marshall Islands\" or Mauritania or Mauritius or \"Agalega Islands\" or Mexico or Micronesia or \"Middle East\" or Moldova or Moldovia or Moldovian or Mongolia or Montenegro or Morocco or Ifni or Mozambique or Myanmar or Myanma or Burma or Namibia or Nepal or \"Netherlands Antilles\" or \"New Caledonia\" or Nicaragua or Niger or Nigeria or \"Northern Mariana Islands\" or Oman or Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or Peru or Philippines or Philipines or Phillipines or Phillippines or Poland or Portugal or \"Puerto Rico\"):ti,ab,kw                                                                                                                                                                                                                                                                                           7142
  \#23   (Romania or Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or \"Saint Kitts\" or \"St Kitts\" or Nevis or \"Saint Lucia\" or \"St Lucia\" or \"Saint Vincent\" or \"St Vincent\" or Grenadines or Samoa or \"Samoan Islands\" or \"Navigator Island\" or \"Navigator Islands\" or \"Sao Tome\" or \"Saudi Arabia\" or Senegal or Serbia or Montenegro or Seychelles or \"Sierra Leone\" or Slovenia or \"Sri Lanka\" or Ceylon or \"Solomon Islands\" or Somalia or Sudan or Suriname or Surinam or Swaziland or Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo or \"Togolese Republic\" or Tonga or Trinidad or Tobago or Tunisia or Turkey or Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or \"Soviet Union\" or \"Union of Soviet Socialist Republics\" or Uzbekistan or Uzbek or Vanuatu or \"New Hebrides\" or Venezuela or Vietnam or \"Viet Nam\" or \"West Bank\" or Yemen or Yugoslavia or Zambia or Zimbabwe or Rhodesia):ti,ab,kw   8710
  \#24   (developing or less\* next developed or \"under developed\" or underdeveloped or \"middle income\" or low\* next income or underserved or \"under served\" or deprived or poor\*) next (countr\* or nation\* or population\* or world):ti,ab,kw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 3803
  \#25   (developing or less\* next developed or \"under developed\" or underdeveloped or \"middle income\" or low\* next income) next (economy or economies):ti,ab,kw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   23
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  46   meta analysis.pt.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       65647
  47   news.pt.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                176635
  48   comment.pt.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             663297
  49   editorial.pt.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           401580
  50   cochrane database of systematic reviews.jn.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             12225
  51   comment on.cm.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          663297
  52   (systematic review or literature review).ti.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            73686
  53   or/44-52                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                7292678
  54   41 not 53                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               4229940
  55   29 and 54                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               4680
  ---- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------

CINAHL, EbscoHost

  ----- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------
  \#    Query                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Results
  S54   S16 AND S34 AND S52 \[Exclude MEDLINE records\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               119
  S53   S16 AND S34 AND S52                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           780
  S52   S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           940,212
  S51   TI (randomis\* or randomiz\* or randomly or trial or effect\* or impact\* or intervention\* or multicenter or \"multi center\" or multicentre or \"multi centre\" or controlled or groups or before N5 after or pre N5 post or ((pretest or \"pre test\") and (posttest or \"post test\")) or quasiexperiment\* or quasi W0 experiment\* or pseudo experiment\* or pseudoexperiment\* or evaluat\* or \"time series\" or time W0 point\* or repeated W0 measur\*) OR AB (randomis\* or randomiz\* or randomly or trial or effect\* or impact\* or intervention\* or multicenter or \"multi center\" or multicentre or \"multi centre\" or controlled or groups or before N5 after or pre N5 post or ((pretest or \"pre test\") and (posttest or \"post test\")) or quasiexperiment\* or quasi W0 experiment\* or evaluat\* or \"time series\" or time W0 point\* or repeated W0 measur\*)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     877,979
  S50   (MH \"Health Services Research\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             7,382
  S49   (MH \"Experimental Studies+\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                168,959
  S48   (MH \"Time Series\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1,612
  S47   (MH \"Multiple Time Series\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 3
  S46   (MH \"Interrupted Time Series Analysis\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     11
  S45   (MH \"Repeated Measures\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    39,029
  S44   (MH \"Multicenter Studies\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  11,769
  S43   (MH \"Quasi-Experimental Studies\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           7,003
  S42   (MH \"Pretest-Posttest Design\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              26,485
  S41   (MH \"Pretest-Posttest Control Group Design\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                403
  S40   (MH \"Nonrandomized Trials\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 170
  S39   (MH \"Intervention Trials\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  5,990
  S38   (MH \"Clinical Trials\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      84,421
  S37   (MH \"Randomized Controlled Trials\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         26,420
  S36   PT clinical trial                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             52,784
  S35   PT randomized controlled trial                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                30,609
  S34   S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           213,994
  S33   TI transitional W0 countr\* OR AB transitional W0 countr\*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    34
  S32   TI ( lmic or lmics or third W0 world or lami W0 countr\* ) OR AB ( lmic or lmics or third W0 world or lami W0 countr\* )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      517
  S31   TI low N3 middle N3 countr\* OR AB low N3 middle N3 countr\*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1,279
  S30   TI ( low\* W0 (gdp or gnp or gross W0 domestic or gross W0 national) ) OR AB ( low\* W0 (gdp or gnp or gross W0 domestic or gross W0 national) )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              16
  S29   TI ( (developing or less\* W0 developed or under W0 developed or underdeveloped or middle W0 income or low\* W0 income) W0 (economy or economies) ) OR AB ( (developing or less\* W0 developed or under W0 developed or underdeveloped or middle W0 income or low\* W0 income) W0 (economy or economies) )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    46
  S28   TI ( (developing or less\* W0 developed or under W0 developed or underdeveloped or middle W0 income or low\* W0 income or underserved or under W0 served or deprived or poor\*) W0 (countr\* or nation or nations or population\* or world or area or areas) ) OR AB ( (developing or less\* W0 developed or under W0 developed or underdeveloped or middle W0 income or low\* W0 income or underserved or under W0 served or deprived or poor\*) W0 (countr\* or nation or nations or population\* or world or area or areas) )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              11,124
  S27   MW ( Afghanistan or Bangladesh or Benin or \"Burkina Faso\" or Burundi or Cambodia or \"Central African Republic\" or Chad or Comoros or Congo or \"Cote d\'Ivoire\" or Eritrea or Ethiopia or Gambia or Ghana or Guinea or Haiti or India or Kenya or Korea or Kyrgyz or Kyrgyzstan or Lao or Laos or Liberia or Madagascar or Malawi or Mali or Mauritania or Melanesia or Mongolia or Mozambique or Burma or Myanmar or Nepal or Niger or Nigeria or Pakistan or Rwanda or \"Salomon Islands\" or \"Sao Tome\" or Senegal or \"Sierra Leone\" or Somalia or Sudan or Tajikistan or Tanzania or Timor or Togo or Uganda or Uzbekistan or Vietnam or \"Viet Nam\" or Yemen or Zambia or Zimbabwe ) or TI ( Afghanistan or Bangladesh or Benin or \"Burkina Faso\" or Burundi or Cambodia or \"Central African Republic\" or Chad or Comoros or Congo or \"Cote d\'Ivoire\" or Eritrea or Ethiopia or Gambia or Ghana or Guinea or Haiti or India or Kenya or Korea or Kyrgyz or Kyrgyzstan or Lao or Laos or Liberia or Madagascar or Malawi or Mali or Mauritania or Melanesia or Mongolia or Mozambique or Burma or Myanmar or Nepal or Niger or Nigeria or Pakistan or Rwanda or \"Salomon Islands\" or \"Sao Tome\" or Senegal or \"Sierra Leone\" or Somalia or Sudan or Tajikistan or Tanzania or Timor or Togo or Uganda or Uzbekistan or Vietnam or \"Viet Nam\" or Yemen or Zambia or Zimbabwe ) or AB ( Afghanistan or Bangladesh or Benin or \"Burkina Faso\" or Burundi or Cambodia or \"Central African Republic\" or Chad or Comoros or Congo or \"Cote d\'Ivoire\" or Eritrea or Ethiopia or Gambia or Ghana or Guinea or Haiti or India or Kenya or Korea or Kyrgyz or Kyrgyzstan or Lao or Laos or Liberia or Madagascar or Malawi or Mali or Mauritania or Melanesia or Mongolia or Mozambique or Burma or Myanmar or Nepal or Niger or Nigeria or Pakistan or Rwanda or \"Salomon Islands\" or \"Sao Tome\" or Senegal or \"Sierra Leone\" or Somalia or Sudan or Tajikistan or Tanzania or Timor or Togo or Uganda or Uzbekistan or Vietnam or \"Viet Nam\" or Yemen or Zambia or Zimbabwe )                                                                                                                                                                                                                                                                                                                                             48,132
  S26   MW ( Albania or Algeria or Angola or Armenia or Azerbaijan or Belarus or Bhutan or Bolivia or Bosnia or Herzegovina or \"Cape Verde\" or Cameroon or China or Colombia or Congo or Cuba or Djibouti or \"Dominican Republic\" or Ecuador or Egypt or \"El Salvador\" or Fiji or Gaza or Georgia or Guam or Guatemala or Guyana or Honduras or \"Indian Ocean Islands\" or Indonesia or Iran or Iraq or Jamaica or Jordan or Kiribati or Lesotho or Macedonia or Maldives or \"Marshall Islands\" or Micronesia or \"Middle East\" or Moldova or Morocco or Namibia or Nicaragua or Palestin\* or Paraguay or Peru or Philippines or Samoa or \"Sri Lanka\" or Suriname or Swaziland or Syria or \"Syrian Arab Republic\" or Thailand or Tonga or Tunisia or Turkmenistan or Ukraine or Vanuatu or \"West Bank\" ) or TI ( Albania or Algeria or Angola or Armenia or Azerbaijan or Belarus or Bhutan or Bolivia or Bosnia or Herzegovina or \"Cape Verde\" or Cameroon or China or Colombia or Congo or Cuba or Djibouti or \"Dominican Republic\" or Ecuador or Egypt or \"El Salvador\" or Fiji or Gaza or Georgia or Guam or Guatemala or Guyana or Honduras or \"Indian Ocean Islands\" or Indonesia or Iran or Iraq or Jamaica or Jordan or Kiribati or Lesotho or Macedonia or Maldives or \"Marshall Islands\" or Micronesia or \"Middle East\" or Moldova or Morocco or Namibia or Nicaragua or Palestin\* or Paraguay or Peru or Philippines or Samoa or \"Sri Lanka\" or Suriname or Swaziland or Syria or \"Syrian Arab Republic\" or Thailand or Tonga or Tunisia or Turkmenistan or Ukraine or Vanuatu or \"West Bank\" ) or AB ( Albania or Algeria or Angola or Armenia or Azerbaijan or Belarus or Bhutan or Bolivia or Bosnia or Herzegovina or \"Cape Verde\" or Cameroon or China or Colombia or Congo or Cuba or Djibouti or \"Dominican Republic\" or Ecuador or Egypt or \"El Salvador\" or Fiji or Gaza or Georgia or Guam or Guatemala or Guyana or Honduras or \"Indian Ocean Islands\" or Indonesia or Iran or Iraq or Jamaica or Jordan or Kiribati or Lesotho or Macedonia or Maldives or \"Marshall Islands\" or Micronesia or \"Middle East\" or Moldova or Morocco or Namibia or Nicaragua or Palestin\* or Paraguay or Peru or Philippines or Samoa or \"Sri Lanka\" or Suriname or Swaziland or Syria or \"Syrian Arab Republic\" or Thailand or Tonga or Tunisia or Turkmenistan or Ukraine or Vanuatu or \"West Bank\" )   52,828
  S25   MW ( \"American Samoa\" or Argentina or Belize or Botswana or Brazil or Brasil or Bulgaria or Chile or Comoros or \"Costa Rica\" or Croatia or Dominica or Guinea or Gabon or Grenada or Grenadines or Hungary or Kazakhstan or Latvia or Lebanon or Libia or libyan or Libya or Lithuania or Malaysia or Mauritius or Mayotte or Mexico or Micronesia or Montenegro or Nevis or \"Northern Mariana Islands\" or Oman or Palau or Panama or Poland or Romania or Russia or \"Russian Federation\" or Samoa or \"Saint Lucia\" or \"St Lucia\" or \"Saint Kitts\" or \"St Kitts\" or \"Saint Vincent\" or \"St Vincent\" or Serbia or Seychelles or Slovakia or \"Slovak Republic\" or \"South Africa\" or Turkey or Uruguay or Venezuela or Yugoslavia ) or TI ( \"American Samoa\" or Argentina or Belize or Botswana or Brazil or Bulgaria or Chile or Comoros or \"Costa Rica\" or Croatia or Dominica or Guinea or Gabon or Grenada or Grenadines or Hungary or Kazakhstan or Latvia or Lebanon or Libia or libyan or Libya or Lithuania or Malaysia or Mauritius or Mayotte or Mexico or Micronesia or Montenegro or Nevis or \"Northern Mariana Islands\" or Oman or Palau or Panama or Poland or Romania or Russia or \"Russian Federation\" or Samoa or \"Saint Lucia\" or \"St Lucia\" or \"Saint Kitts\" or \"St Kitts\" or \"Saint Vincent\" or \"St Vincent\" or Serbia or Seychelles or Slovakia or \"Slovak Republic\" or \"South Africa\" or Turkey or Uruguay or Venezuela or Yugoslavia ) or AB ( \"American Samoa\" or Argentina or Belize or Botswana or Brazil or Bulgaria or Chile or Comoros or \"Costa Rica\" or Croatia or Dominica or Guinea or Gabon or Grenada or Grenadines or Hungary or Kazakhstan or Latvia or Lebanon or Libia or libyan or Libya or Lithuania or Malaysia or Mauritius or Mayotte or Mexico or Micronesia or Montenegro or Nevis or \"Northern Mariana Islands\" or Oman or Palau or Panama or Poland or Romania or Russia or \"Russian Federation\" or Samoa or \"Saint Lucia\" or \"St Lucia\" or \"Saint Kitts\" or \"St Kitts\" or \"Saint Vincent\" or \"St Vincent\" or Serbia or Seychelles or Slovakia or \"Slovak Republic\" or \"South Africa\" or Turkey or Uruguay or Venezuela or Yugoslavia )                                                                                                                                                                                                  62,809
  S24   TI ( Africa or Asia or \"South America\" or \"Latin America\" or \"Central America\" ) or AB ( Africa or Asia or \"South America\" or \"Latin America\" or \"Central America\" )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              14,134
  S23   (MH \"Asia+\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                99,994
  S22   (MH \"West Indies+\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         5,217
  S21   (MH \"South America+\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       25,838
  S20   (MH \"Latin America\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1,323
  S19   (MH \"Central America+\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     2,168
  S18   (MH \"Africa+\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              32,362
  S17   (MH \"Developing Countries\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 8,973
  S16   S13 OR S14 OR S15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             8,805
  S15   TI (immunization or immunisation or vaccination) W0 (program\* or rate\* or coverage or adher\*)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1,249
  S14   TI ( (vaccinat\* or revaccinat\* or immunization or immunisation) N3 (child\* or infant or infants or newborn or neonat\* or baby or babies or kid or kids or toddler\* or woman or women or mother\*) ) OR AB ( (vaccinat\* or revaccinat\* or immunization or immunisation) N3 (child\* or infant or infants or newborn or neonat\* or baby or babies or kid or kids or toddler\* or woman or women or mother\*) )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          3,345
  S13   S5 AND S12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    6,586
  S12   S6 OR S7 OR S8 OR S9 OR S10 OR S11                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            320,243
  S11   (MH \"Expectant Mothers\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2,193
  S10   (MH \"Women\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                11,013
  S9    (MH \"Mothers\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              13,932
  S8    (MH \"Infant, Newborn\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      65,336
  S7    (MH \"Infant\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               83,244
  S6    (MH \"Child\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                220,709
  S5    S1 or S2 or S3 or S4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          18,740
  S4    (MH \"Immunization Programs\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                3,081
  S3    (MH \"Immunotherapy\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2,729
  S2    (MH \"Immunization Schedule\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1,940
  S1    (MH \"Immunization\")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         12,688
  ----- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------

[**EMBASE (Ovid)**]{.ul}

  ----- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------
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  1     Immunization/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        75,652
  2     Active Immunization/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 6595
  3     Mass Immunization/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2421
  4     Vaccination/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         96,045
  5     Revaccination/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1059
  6     (vaccinat\$ or revaccinat\$ or immunization or immunisation or immunotherapy).tw.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    226,888
  7     or/1-6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               289,620
  8     Tetanus Prophylaxis/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 1259
  9     BCG Vaccination/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     7072
  10    Measles Vaccination/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 2189
  11    or/8-10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              10,339
  12    Tetanus Toxoid/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      10,548
  13    Diphtheria Toxoid/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2535
  14    Diphtheria Toxoid crm197/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            216
  15    Diphtheria Tetanus Toxoid/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           427
  16    BCG Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         27,645
  17    Diphtheria Pertussis Poliomyelitis Tetanus Haemophilus Influenzae Type B Hepatitis B Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        380
  18    Diphtheria Pertussis Poliomyelitis Tetanus Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  393
  19    Diphtheria Pertussis Tetanus Haemophilus Influenzae Type B Hepatitis B Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      158
  20    Diphtheria Pertussis Tetanus Haemophilus Influenzae Type B Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  464
  21    Diphtheria Pertussis Tetanus Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                6524
  22    Diphtheria Poliomyelitis Tetanus Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            74
  23    Diphtheria Tetanus Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          675
  24    Diphtheria Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1902
  25    Haemophilus Influenzae Type B Hepatitis B Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   230
  26    Haemophilus Influenzae Type B Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               4269
  27    Haemophilus Influenzae Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      944
  28    Haemophilus Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 764
  29    Pertussis Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   6378
  30    Triple Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      715
  31    Hepatitis a Hepatitis B Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     502
  32    Hepatitis B Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 15,773
  33    Hepatitis Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2126
  34    Recombinant Hepatitis B Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1776
  35    Measles Mumps Rubella Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       5594
  36    Measles Mumps Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               102
  37    Measles Rubella Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             100
  38    Measles Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     7860
  39    Mumps Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       2031
  40    Rubella Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     3477
  41    Chickenpox Measles Mumps Rubella Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            219
  42    Poliomyelitis Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               7207
  43    Oral Poliomyelitis Vaccine/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          4250
  44    ((tetanus or diphtheria) adj toxoid).tw.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             5484
  45    ((tetanus or diphtheria? or pertussis or whooping cough or measles or mumps or rubella? or rubeola or mmr or polio\$ or tuberculosis or tuberculoses or bcg or calmette\$ or hepatitis b or haemophilus or triple) adj vaccine?).tw.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 17,760
  46    or/12-45                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             86,597
  47    Tetanus/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             12,351
  48    Diphtheria/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          9102
  49    Measles/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             15,582
  50    Mumps/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               5967
  51    Rubella/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             9019
  52    Pertussis/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           10,521
  53    Poliomyelitis/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       18,525
  54    Tuberculosis/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        89,886
  55    Lung Tuberculosis/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   63,542
  56    Mycobacterium Tuberculosis/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          48,597
  57    Hepatitis B/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         69,010
  58    Chronic Hepatitis/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   21,541
  59    Haemophilus Influenzae/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              18,964
  60    Haemophilus Influenzae Type B/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       3868
  61    (tetanus or diphtheria? or measles or rubella? or rubeola or mumps or epidemic parotit\$ or pertussis or whooping cough or polio\$ or infantile paralysis or tuberculosis or tuberculoses or hepatitis b or haemophilus influenza?).tw.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              333,094
  62    or/47-61                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             440,846
  63    exp Child/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2,005,016
  64    exp Newborn/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         450,384
  65    Child Care/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          30,274
  66    (child\$ or infant? or newborn? or neonat\$ or baby or babies or kid? or toddler?).tw.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1,614,491
  67    or/63-66                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             2,499,583
  68    7 and (Tetanus/ or tetanus.tw.)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      10,450
  69    Tetanus Toxoid/ or Tetanus Prophylaxis/ or (tetanus toxoid or tetanus vaccin\$ or tetanus prophylaxis).tw.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           13,141
  70    or/68-69                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             18,159
  71    exp Mother/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          86,127
  72    Female/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              5,983,316
  73    (woman or women or mother? or female?).tw.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1,819,414
  74    or/71-73                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             6,295,611
  75    70 and 74                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            5326
  76    Developing Country.sh.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               75,918
  77    (Africa or Asia or Caribbean or West Indies or South America or Latin America or Central America).hw,ti,ab,cp.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       227,844
  78    (Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or Brasil or Bulgaria or Burkina Faso or Burkina Fasso or Upper Volta or Burundi or Urundi or Cambodia or Khmer Republic or Kampuchea or Cameroon or Cameroons or Cameron or Camerons or Cape Verde or Central African Republic or Chad or Chile or China or Colombia or Comoros or Comoro Islands or Comores or Mayotte or Congo or Zaire or Costa Rica or Cote d\'Ivoire or Ivory Coast or Croatia or Cuba or Cyprus or Czechoslovakia or Czech Republic or Slovakia or Slovak Republic or Djibouti or French Somaliland or Dominica or Dominican Republic or East Timor or East Timur or Timor Leste or Ecuador or Egypt or United Arab Republic or El Salvador or Eritrea or Estonia or Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or Gaza or Georgia Republic or Georgian Republic or Ghana or Gold Coast or Greece or Grenada or Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary or India or Maldives or Indonesia or Iran or Iraq or Isle of Man or Jamaica or Jordan or Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or Kirghizia or Kyrgyz Republic or Kirghiz or Kirgizstan or Lao PDR or Laos or Latvia or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania or Macedonia or Madagascar or Malagasy Republic or Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi or Nyasaland or Mali or Malta or Marshall Islands or Mauritania or Mauritius or Agalega Islands or Mexico or Micronesia or Middle East or Moldova or Moldovia or Moldovian or Mongolia or Montenegro or Morocco or Ifni or Mozambique or Myanmar or Myanma or Burma or Namibia or Nepal or Netherlands Antilles or New Caledonia or Nicaragua or Niger or Nigeria or Northern Mariana Islands or Oman or Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or Peru or Philippines or Philipines or Phillipines or Phillippines or Poland or Portugal or Puerto Rico or Romania or Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or Saint Kitts or St Kitts or Nevis or Saint Lucia or St Lucia or Saint Vincent or St Vincent or Grenadines or Samoa or Samoan Islands or Navigator Island or Navigator Islands or Sao Tome or Saudi Arabia or Senegal or Serbia or Montenegro or Seychelles or Sierra Leone or Slovenia or Sri Lanka or Ceylon or Solomon Islands or Somalia or Sudan or Suriname or Surinam or Swaziland or Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo or Togolese Republic or Tonga or Trinidad or Tobago or Tunisia or Turkey or Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or Soviet Union or Union of Soviet Socialist Republics or Uzbekistan or Uzbek or Vanuatu or New Hebrides or Venezuela or Vietnam or Viet Nam or West Bank or Yemen or Yugoslavia or Zambia or Zimbabwe or Rhodesia).hw,ti,ab,cp.   2,838,905
  79    ((developing or less\* developed or under developed or underdeveloped or middle income or low\* income or underserved or under served or deprived or poor\*) adj (countr\* or nation? or population? or world)).ti,ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               68,123
  80    ((developing or less\* developed or under developed or underdeveloped or middle income or low\* income) adj (economy or economies)).ti,ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           351
  81    (low\* adj (gdp or gnp or gross domestic or gross national)).ti,ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  187
  82    (low adj3 middle adj3 countr\*).ti,ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               4139
  83    (lmic or lmics or third world or lami countr\*).ti,ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               3741
  84    transitional countr\*.ti,ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         138
  85    or/76-84                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             3,019,888
  86    Randomized Controlled Trial/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         348,266
  87    Controlled Clinical Trial/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           386,406
  88    Quasi Experimental Study/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            2013
  89    Pretest Posttest Control Group Design/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               206
  90    Time Series Analysis/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                14,239
  91    Experimental Design/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 10,019
  92    Multicenter Study/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   109,759
  93    (randomis\* or randomiz\* or randomly or random allocat\*).ti,ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    727,521
  94    groups.ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1,698,086
  95    (trial or multicentre or multicenter or multi centre or multi center).ti.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            192,503
  96    (intervention\* or controlled or control group or compare or compared or (before adj5 after) or (pre adj5 post) or pretest or pre test or posttest or post test or quasiexperiment\* or quasi experiment\* or evaluat\* or effect or impact or time series or time point? or repeated measur\*).ti,ab.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               8,028,793
  97    or/86-96                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             8,766,538
  98    (systematic review or literature review).ti.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         62,313
  99    \"cochrane database of systematic reviews\".jn.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      3777
  100   Nonhuman/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            4,359,920
  101   or/98-100                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            4,424,301
  102   97 not 101                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           6,927,465
  103   7 and 62 and 67 and 85 and 102                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       4433
  104   11 and 67 and 85 and 102                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             865
  105   46 and 67 and 85 and 102                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             4231
  106   103 or 104 or 105                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    5462
  107   limit 106 to embase                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  4043
  ----- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------

[**Sociological Abstracts (ProQuest)**]{.ul}

ALL(vaccination or vaccine or vaccines or immunization)

AND

ALL(child\* or infant\* or newborn or neonat\* or baby or babies or kid or kids or toddler\* or mother\* or woman or women or female)

[**LILACS (VHL)**]{.ul}

(immunization or inmunizacion or imunizacao or vaccination or vacunacion or vacinacao or vaccine or vaccines or vacuna or vacunas or vacina or vacinas) **AND** (tetanus or tetanico or diphtheria or difterico or pertussis or \"whooping cough\" or tosferina or \"tos ferina\" or \"tos convulsa\" or \"tosse convulsa\" or coqueluche or measles or sarampion or sarampo or mumps or paperas or caxumba or rubella or rubeola or mmr or polio\* or tubercul\* or \"mycobacterium bovis\" or bcg or calmette\* or hepatitis or hepatite or haemophilus) **AND** (child or children or infant or infants or newborn or neonat\* or baby or babies or kid or kids or toddler\* or nino or ninos or crianca or criancas or lactante\* or lactente\* or \"recien nacido\" or \"recien nacidos\" or \"recem nascido\" or \"recem nascidos\") **AND** (randomi\* or randomly or azar or acaso or control\* or intervention\* or evaluat\* or effect\* or impact or impacts or intervencion\* or intervencao\* or evaluar or evaluacion or avaliacao or efecto or efectos or efeito or efeitos or impacto or impactos or \"serie de tiempo\" or \"series de tiempo\" or \"serie de tempo\" or \"series de tempo\" or \"serie temporal\" or \"series temporal\" or \"serie temporales\" or \"series temporales\" or \"serie temporais\" or \"series temporais\" or \"puntos de tiempo\" or \"pontos de tiempo\" or \"puntos de tempo\" or \"puntos de tempo\" or \"puntos temporales\" or \"pontos temporales\" or \"punto temporais\" or \"ponto temporais\" or \"medida repetida\" or \"medida repetidas\" or \"medidas repetida\" or \"medidas repetidas\" or \"medicion repetida\" or \"medicion repetidas\" or \"mediciones repetida\" or \"mediciones repetidas\")

What\'s new
===========

Last assessed as up-to-date: 5 July 2016.

  -------------- ---------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------
  Date           Event                                                Description
  22 June 2016   New citation required and conclusions have changed   Eight new studies were added to this update and the conclusions have changed.
  22 June 2016   New search has been performed                        This is the first update of the Cochrane review published in 2011. We conducted a new search and updated other content. New authors were also added.
  -------------- ---------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------

Contributions of authors
========================

AO: screening, data extraction, analysis, and write up.
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Differences between protocol and review
=======================================

We have changed the first primary outcome from \'Number of children aged two years fully immunised per vaccine\' in the previous version of this review to the first primary outcome \'Proportion of children who received DTP3 by one year of age\' in this present review. The latter is a widely accepted standard measure of a childhood immunisation programme\'s ability to reach the target population.
